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Abstract 
Magnetic Resonance Imaging (MRI) produces superior soft tissue contrast that is 
mostly determined by the tissue relaxation times (T1 and T2) and spin density (PD). This 
dissertation introduces novel methods to quantify T1, T2 and PD, and explored their value 
for disease classification, and tracking delivery of cell therapies. 
 First, a novel T2 measurement (Dual-τ) method that employs adiabatic pulses is 
proposed, that exploits the property that the spins undergo T2 decay during excitation by 
long adiabatic pulses. The new method is relatively immune to MR static and excitation 
field inhomogeneity, and has a higher efficiency than the conventional methods. The 
adiabatic excitation pulse can also serve as a preparation pulse that introduces T2 contrast 
into the MRI, and can be combined with T1 quantification methods to produce T1 and T2 
simultaneously. The method is shown to be most accurate at short T2s. The T2 
measurements were validated in phantoms and in vivo in human studies.  
Second, three methods of mapping T1, T2, and PD simultaneously with the least 
possible number of acquisitions are presented, also utilizing adiabatic pulses. The first, 
Dual-τ-Dual-FA method, encodes T1 by varying excitation flip-angle (FA). The second, 
Dual-τ-Dual-TR method, encodes T1 using the variations in the sequence repetition time 
(TR). The third method incorporates the FA self-correction to eliminate T1 errors caused 
by field inhomogeneities, and is called the Four-FA method. All three methods were 
validated in phantom studies, and the Dual-τ-Dual-FA and Four-FA methods were 
validated in human brain studies as well. The Four-FA method is demonstrated to have 
the best overall accuracy compared to the existing methods, such as DESPOT1/2, IR 
TrueFISP, etc. 
 iii 
Combining the multi-parametric mapping methods with intravascular (IV) MRI 
potentially offers a means of reducing the scan time and increasing the local SNR. For the 
first time, multi-parametric high-resolution (<200μm) T1, T2, PD and fat images of 
human vessels are obtained. These maps were used to train a machine-learning based 
classifier to automatically distinguish early- and advanced-stage vessel disease from 
healthy and smooth muscle. This application enables differentiation of vessel wall disease 
types with high sensitivity and specificity compared with histology as the standard.  
The contrast of cells delivered as therapeutic agents in MRI can be enhanced 
using capsules impregnated with MRI-sensitive contrast agents. At the end of the 
dissertation, we explore quantitative cell tracking using 19F-labeled capsules that provide 
dual modality contrast for both computed tomography (CT) and MRI. The method was 
validated in rabbit diseased models using clinical imaging systems. Compared with CT, 
19F MRI was able to accurately track cells non-invasively in vivo, without the use of 
ionizing radiation. Two weeks after the cell administration, no significant changes in the 
volume or concentration of the capsules were observed, and the cells preserved high 
viability according to histology.  
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Chapter 1. Introduction 
 
1.1 Overview of the thesis 
Magnetic Resonance Imaging (MRI) is a technique that was developed in the 
1970s[1], and has been widely applied in medical diagnosis and treatment since its first 
clinical use in the 1980s. It was first referred to as Zeugmatography, then “nuclear” 
magnetic resonance (NMR) imaging, even though there is no ionizing radiation involved. 
During an MRI scan, a body in the strong magnetic field is excited by radio frequency 
(RF) waves, assembled into RF pulse sequences, and then, as the nuclear magnetization 
gradually recovers to equilibrium, the body re-emits signal. MRI has no known health 
risks, although the magnets can attract ferromagnetic projectiles. The RF wave from an 
MR scanner is in the electromagnetic spectrum, as are the RF waves emitted from our 
cell phones, radios, TVs, and microwave ovens, which operate at different frequencies. 
To overcome physicians’ fear associated with the word “nuclear,” NMR was renamed 
MRI. In fact, my co-advisor William A. Edelstein and advisor Paul A. Bottomley wrote a 
letter to the editor of Radiology in 1984 to explain that there was no reason to fear, 
because all matter is made of nuclei, “which are not about to explode”[2]. The editor 
agreed with them, but responded that “the educational effort” was unlikely to be 
successful in the near-term. 
 In addition to its safety, another great advantage of MRI is its versatility. This 
resulted in extensive research that has fostered many innovations over the years. Here, 
“versatility” has two interpretations. In a narrow sense, it means that MRI can be 
performed in any arbitrary plane in either two dimensions (2D) or three dimensions (3D). 
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In a broader sense, MRI is flexible in terms of image contrast. Because the signal source 
lies in the body, the signal is largely dependent on many local tissue characteristics: the 
nuclear density; the motion of the nuclear signal sources; temperature; the chemical 
environment of the nuclei; tissue heterogeneity; etc. Indeed, MRI produces soft tissue 
contrast superior to that of any other imaging modalities. Among all these characteristics, 
the three tissue parameters: the nuclear spin density (PD), the spin-lattice relaxation time 
(T1), and the spin-spin relaxation time (T2) of the water protons (
1H), are essential for 
controlling the contrast in routine MRI. How to produce these three parameters and 
generate contrast-optimized magnetic resonance (MR) images for tissue differentiation 
and disease diagnosis is a stimulating topic in MRI research, and forms the basis for this 
thesis. 
 However, although MRI is versatile and safe, it cannot always replace other 
imaging modalities, even for soft tissue imaging. As well as the bulk size, high 
maintenance cost, and noisy acquisitions of MR scanners, a major drawback is the 
relatively slow speed. The signal-to-noise ratio (SNR) is proportional to the square root 
of the acquisition time, and thus, reducing the scan time causes a loss of signal, and may 
render images more susceptible to artifacts as well. One effective metric by which to 
evaluate MRI sequences is efficiency-per-unit-accuracy of the signal or parameter being 
imaged. The sequence with the highest efficiency-per-unit-accuracy requires the shortest 
acquisition time to reach the same signal precision and accuracy. For the new MRI 
sequences presented in this thesis, the efficiency-per-unit-accuracy has been compared 
with existing sequences and the results are reported. 
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 After the three main parameters are produced by high-efficiency-per-unit-
accuracy sequences, the question becomes: “What combination of the three parameters 
will yield an image whose contrast can best help diagnosing a given medical condition?” 
In other words, how can we best increase the contrast between pathological and healthy 
tissue using the information from the three parameters? This is an optimization problem 
that is similar to finding the global minimum solution in a 3D (or higher) space. 
Obviously, the optimum solution varies for different types of disease, thus the weights for 
combining the three parameters would also change. Radiologists choose to perform T1-
weighted, T2-weighted, or PD-weighted sequences for disease diagnoses based on 
empirical experience, but there is no quantitative guideline for producing optimized 
contrast images. 
 When cells are to be imaged, the contrast enhancement based on the three main 
MRI parameters and the spatial resolution are usually not sufficient to distinguish 
individual cells. In this case, a cell-labeling technique was invented to further increase the 
contrast with special reporter probes that allow the cells to be visualized [3]. The cell 
labeling probe can be negative, such as with iron oxide-based contrast agents that induce 
dark susceptibility artifacts at the cell’s location[4]. However, the dark signal from the 
cells may be offset because the surrounding tissue 1H signal confounding its 
differentiation. Labeling the cells with an NMR nucleus that does not normally exist in 
the tissue can provide strong signal hot spots if MRI is performed of the new nucleus, 
without proton signal contamination from tissue. Due to the near-absence of fluorine 
(19F) in nearly all mammalian tissues, 19F MRI could advantageously generate positive 
signals with NMR sensitivity comparable to that of 1H MRI [5, 6]. MRI-based cell-
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tracking is a rapidly developing field, and there is hope that it will not only allow 
localized detection, but also enable quantification of the cell count in vivo. 
 Thus, this thesis explores MRI contrast in many aspects, from its fundamental 
mechanisms, the development of MRI methods to quantify T1, T2 and PD, to its 
applications in automatic disease classification, and quantitative cell-tracking employing 
19F MRI.  
 The remainder of this chapter will describe the fundamental concepts of NMR and 
MRI contrast. The basis of T1 and T2 and the conventional methods of measuring them 
are introduced. In addition, methods to improve contrast, including contrast agents are 
explored.  
In Chapter 2, the development of a new T2 measurement and imaging sequence that 
employs long adiabatic excitation pulses without the conventional spin echoes is reported. 
The new method has the advantages of immunity to static and excitation field 
inhomogeneity, and efficiency. The adiabatic excitation pulse can also serve as a 
preparation pulse that introduces T2 contrast into the images, which can then be combined 
with T1 quantification methods to produce simultaneously T1 and T2.  
Chapter 3 builds on this work to develop several methods of mapping T1, T2, and PD 
with a minimum number of acquisitions. Based on the T2 provided by the adiabatic 
pulses, the T1 contrast is introduced using either variations in flip-angle (FA) or the 
sequence repetition time (TR), in the new Dual- Dual-FA method and Dual- Dual-TR 
methods. However, T1 measurements are very sensitive to inhomogeneity in the 
excitation field (B1). Thus, we incorporated one more acquisition to create a set of 4 
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acquisitions to provide T1, T2, and PD maps that incorporate a B1-field inhomogeneity 
self-correction. This set of acquisitions is called the ‘Four-FA’ sequence.  
In Chapter 4 we use the measured parameters to distinguish vessel wall disease. 
Autopsied vessel specimens were imaged with interventional MRI coils using T1, T2, and 
PD quantification sequences. A 3D space is constructed in which each axis corresponds 
to one of these parameters. A machine-learning algorithm was trained to partition the 
space into sub-spaces, compromised different stages of disease. This application enabled 
differentiation of tissue types for disease classification with high sensitivity and 
specificity.  
Finally, in Chapter 5, we explore quantitative cell tracking using 19F-labeling. The 
19F labeling is introduced by impregnating the cell capsules with perfluoro-octyl-bromide 
(PFOB). Compared with X-ray computed tomography (CT), MRI was able to accurately 
track cells non-invasively in vivo, without the use of ionizing radiation.    
1.2 MR Basics 
1.2.1 History of MR 
In 1937, Isidor Isaac Rabi, an American physicist from Columbia University, 
recognized that the atomic nuclei absorb or emit radio waves when exposed to a magnetic 
field, and was first to use the magnetic resonance method to observe atomic spectra[7, 8]. 
He was awarded the Nobel Prize for Physics in 1944 for this work[9]. In 1946, Felix 
Bloch and Edward Mills Purcell independently, but contemporaneously, demonstrated 
the “nuclear magnetic resonance” phenomenon. They developed similar methods to 
measure the magnetic moments of nuclei, and shared the Nobel Prize in 1952 [10, 11]. 
Later, Purcell, along with Nicolaas Bloembergen and Robert Pound published a 
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comprehensive theory of nuclear magnetic relaxation[12]. The landmark article is known 
as the “BPP” paper, and is one of the foundations in NMR physics. In 1950, Erwin Hahn 
introduced the pulse NMR experiment and discovered the “spin-echo” phenomenon 
which he used to measure NMR T2 values[13]. In the 1960s, Richard R. Ernst and 
Weston A. Anderson showed that Fourier transforming (FT) the time-domain NMR 
signal from the pulsed NMR experiment greatly improved the SNR of the NMR spectrum 
for chemical analysis, allowing high-resolution analysis of many more types of nuclei. 
Ernst won the Nobel Prize in Chemistry in 1991 for this contribution[14]. Allan M. 
Cormack and Godfrey N. Hounsfield developed the CT scanner in 1970s, with the 
reconstruction-from-projection technique. This inspired Paul C. Lauterbur to reconstruct 
the first MR image by coupling the CT projection reconstruction and the gradient concept 
to generate angular projections through a sample[1]. Sir Peter Mansfield pushed the 
transition from NMR to MRI forward with the development of echo-planar imaging, 
which allowed the creation of a 2D MRI within one excitation[15]. Lauterbur and 
Mansfield were both awarded the Nobel Prize in Physiology or Medicine in 2003 for 
their work in MRI. In 1986, Kurt Wuthrich developed the NMR spectroscopy method to 
determine the 3D structure of biological macromolecules in solution[16], for which he 
shared the 1999 Nobel Prize in Chemistry[17]. 
During the 1970s, John Mallard’s team built the first full-body MRI scanner at the 
University of Aberdeen. My former co-advisor William Edelstein was part of this group 
which performed the first clinical study on a patient in August, 1980[18]. Dr. Edelstein 
was also the primary inventor of “spin-warp,” the 2D FT-based technique that has 
dominated the spatial encoding since then[19]. In 1980, my advisor, Paul Bottomley, and 
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his team ordered the highest field magnet available at that time—a1.5 Tesla (T)—and 
built the first high-field whole-body MRI/MRS scanner, increasing the field strength 
almost four times from 0.4 T. According to the market report of 2013[20], 1.5T MRI 
scanners still represent more than 60% market share. Recently, higher-field-strength (3T-
7T) scanners have gained a foothold in an increasing number of institutions, and human 
MRI studies have now been performed at fields of 9.4T[21], while animal MRI studies 
have been performed at 21.1T[22]. 
1.2.2 MR Physics 
The NMR phenomenon occurs in atoms with an odd number of protons or neutrons, 
such as 1H, 31P, 23Na, 19F, etc. These atoms possess spin angular momentum, and are 
called “spins.” The spins in the magnetic field produce an effective “magnetic dipole 
moment.” The average magnetic dipole moment density per volume is called the nuclear 
magnetization, M. Unless stated otherwise, the 1H nucleus is the subject of the rest of the 
thesis. 
 In the quantum mechanical view, in the presence of a static magnetic field B0 
directed, by convention, along the z-axis of a Cartesian coordinate frame, the number of 
nuclei that are parallel to the field exceeds those that are anti-parallel (Fig 1.1a). We 
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Planck’s constant, T is absolute temperature, k is the Boltzmann’s constant, and γ is a 
constant named the gyromagnetic ratio. For 1H, γ/2π = 42.58 MHz/T.  
In all the applications and temperatures considered here, we have ΔE<<kT, 








/ 2,  n- - n+ ≪ r0 / 2
. M0 is then found as 
   [1.1] 
At a human body temperature of 37 ºC, the excess is about 5 out of every 106 spins at 
1.5T. [23]  
If M does not align with the field, it will precess about the field at the “Larmor 
frequency”, given by 
   [1.2] 
Clearly, the Larmor frequency depends linearly on the field strength.  
When a RF magnetic field B1 rotating at the Larmor frequency ω is applied in the 
transverse direction (x-y plane), M will be rotated away from the longitudinal direction 
(z-axis) by a flip angle (FA, Fig1.1b). This process is called an excitation. Following the 
excitation, M will continue to precess about the z-axis, and the component in the x-y 
plane, Mxy will produce a RF signal, often called a free induction decay (FID), which can 
be detected via Faraday’s law of induction. The devices used to transmit B1 or receive 
FID are called RF coils. At the same time, the longitudinal component of M (Mz) will 
regrow while Mxy will decay, until M returns to the equilibrium state. Relaxation time 
constants T1 and T2 measure the return of Mz and Mxy to the equilibrium, respectively 
(Fig 1.1c-d). The mechanisms of T1 and T2 are elaborated in Section 1.3. For convenience, 






a frame of reference x’-y’ rotating about z at ω is conventionally introduced to simplify 
the motion of M (Fig 1.1e).  
 
Fig 1.1 (a) Applied B0 field and magnetization M. The B0 direction is defined as the z-axis, 
and the perpendicular plane is called the transverse (or x-y) plane. (b) RF B1 excitation 
at the Larmor frequency. M is tipped away from z while precessing about z at the same 
frequency. (c) Mz and (d) Mxy during relaxation back to equilibrium. (e) The rotation 
frame-of-view following a 90° excitation, with the x-y plane rotating at the Larmor 
frequency. The rotation frame is denoted x’-y’. Fig1.1 is from Nishimura [24]. 
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  [1.3] 
with i, j, k the unit vectors in x, y, z directions. The cross product on the right describes 
what happens during the B1 pulse, the 2






To localize the signal source, a magnetic gradient field pointing in the z direction is 
added to the B0. The added field strength can be varied linearly in any of the x, y, z 
directions, with the gradients denoted Gx, Gy, Gz corresponding to ∂B0/∂x, ∂B0/∂y, ∂B0/∂z 
respectively. After the application of the gradient field, or “gradients” for short, the 
Larmor frequency of the spin at (x, y, z) becomes 
. For simplicity, from hereafter in this section, 
we will ignore the T2 decay and assume the signals are from the transverse 2D plane at 
z=0. Then, based on the Bloch equation, with a time varying gradient G(t), the received 
signal for the transverse plane is 
   [1.4] 
where  , , m(x,y) is the integral of M(x,y,z) 
over z. We immediately associate the signal equation with a FT. Indeed, the signal 
equation can be alternatively written as the FT of m(x,y),  
   [1.5] 
 When the gradient is on (Gx≠0 or Gy≠0), the signal received at the time t equals the 
2D FT of m(x,y) at the spatial frequency (kx(t), ky(t)).  The Fourier space is called k-
space in MRI in analogy to X-ray crystallography. By controlling Gx and Gy in [1.5], the 
signal can be acquired at different k-space positions. Therefore the gradients determine 
the k-space trajectory. Spatially encoding the spins in the x direction using Gx is called 
frequency encoding, while encoding in the y direction using Gy is called phase encoding.  
To excite only a plane in the object instead of the whole object, a slice selection 
gradient Gz is added. This will result in the excitation of only the spins on resonance at 
 
w =g (B0 +Gxx+Gyy+Gzz)= g (B0 +Gir)
s(t) = m(x, y)e
















Gz=0, which is defined by the user. A phase shift caused by Gz during the application of 
the RF pulse can be removed by reversing the Gz for half of the pulse duration after the 
pulse. A pulse sequence timing diagram describes the timing of applying a RF excitation 
pulse and the gradients (Fig 1.2a-b).  
To reconstruct the image m(x,y), we need a sufficient poriton of k-space to be 
covered. Assuming signals are acquired by sampling with the periods Δkx, Δky, and the 
highest sampled spatial frequencies are kxmax, kymax (Fig 1.2 c), we are able to generate an 
image with a field-of-view (FOV) and a special resolution δ as follows,   
   [1.6] 
   [1.7] 




















Fig 1.2(a) A pulse sequence timing diagram showing the application of a RF pulse and 
the Gx, Gy gradients. (b) The corresponding k-space trajectory. After RF excitation, Gy is 
turned on first. Ky is the time integral of Gy, thus ky(t) increases until Gy turns back to 
zero when it stops increasing. Similarly, when Gx is turned on, the sampled signal 
corresponds to a horizontal line in k-space. (c) Sampling in k-space. (d) Corresponding 
spatial domain. The sampling period controls the FOV, while the highest sampled 
frequency determines the image resolution. Fig1.2 is from Nishimura [24]. 
 
An MR image is generated by Fourier transforming the sampled k-space data into the 
spatial domain. These are the basic imaging principles of MRI. 
1.3 Relaxation times 
Here, the T1 and T2 relaxation times are discussed in detail. Their mechanisms, 
dependence on environmental factors and tissue characteristics, value in the disease 









1.3.1 Defining relaxation 
T1 characterizes the relaxation of excited spins to the equilibrium state in the 
longitudinal direction. The relaxation involves energy-state transitions. From the 
quantum mechanics view, for a spin-1/2 NMR nucleus, the spins and the lattice are in 
either of the two states: the high-energy state m=-1/2 (i.e., anti-parallel to B0) or the low-
energy state m=+1/2(i.e., parallel to B0). The energy transition between the spins and the 
lattice can be described as 
   [1.8] 
Where  is the spin excess pointing in the +z direction, with N+ and N- 
referring to the number of spins in the lower and higher energy states respectively. (ΔN)0 
is ΔN at equilibrium. The energy exchange rate between the spins and the lattice defines 
T1, spin-lattice relaxation constant. Integrating Eq [1.8] over a volume actually yields the 
longitudinal part of the Bloch equation [1.3]. 
At equilibrium, by definition, there is an equal probability for the energy jump 
upward and downward, the number of spins in each state is dynamically balanced with a 
slight excess in the low energy state, as given by the Boltzman distribution. The RF 
pulses transmit energy to the system, resulting in more anti-parallel spins corresponding 
to the high-energy state. To return to equilibrium requires spin transition from m=-1/2 to 
m=+1/2 at the decay rate, T1, such that ∆N->(∆N)0. Eventually, at equilibrium, resulting 
in [23]. The general solution to the differential equation [1.8] of longitudinal 
magnetization at time t in the absence (or between) B1 excitation pulses is: 
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M z(t) = M0 + (M z(0)-M0 )e
-t /T1
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T2 is the time constant that describes the decay of Mxy due to the phase incoherence 
in the transverse plane, in addition to T1 relaxation. The interactions between the spins 
result in a local field disturbance ΔB(t), causing the dephasing of the spins and a reduced 
MR signal from a volume. The general solution to the transverse part of the Bloch 
equation at time t (between excitation pulses) is: 
 M xy(t) = M xy(0)e
-t /T2   [1.10] 
1.3.2 What decides T1 and T2?  
Many models have been developed to explore factors that affect relaxation. 
Presented here are the dominant BPP theory [12], and the fast exchange two-state (FETS) 
model describing its application to tissue[25]. 
The energy state transitions of the spins are always stimulated by the surrounding 
magnetic field perturbation resulted from molecular tumbling motion in which the spins 
behave as magnetic dipoles. The energy exchange is thermal. The probability of 
transition is related to the amount of perturbations at the resonance frequency. The 
average time duration of a spin interacting with the magnetic perturbations is called the 
correlation time (τc). In the BPP theory of dipole relaxation, T1 and T2 are decided by τc 
(Fig 1.3a):    
   [1.11] 
   [1.12] 
Where ω0 is the Larmor frequency and K is a constant (~10
10s-2). For bulk water, 
molecules move very fast; thus, τc is very short (~10
-12s), ω0τc<<1, and T1≈T2. For solid, 
molecules are tightly bounded and τc becomes very long (~10































Consequently solids tend to have very long T1s and ultra short T2s. For viscous liquid, τc 
is about 10-9s, which is near the minimum of the T1 curve in Fig 1.3a. T1 and T2 values of 
the viscous liquids are typically closer to each other than those of solids, but further apart 
than those of low-viscousity liquids. The T1 of viscous liquid is clearly frequency 
dependent in this case (Fig 1.3b). 
 
Fig 1.3. (a) T1 and T2 relaxation times as a function of correlation time τc. Viscous liquid 
has the lowest T1. (b) Substance spectrum distribution vesus (vs.) frequency ω for solid, 
liquid and viscous liquid. T1 is shortened when the shaded area is increased by imaging 
at lower ω0. Fig 1.3(a) is from [12] and Fig 1.3(b) is from [26]. 
 
BPP theory is fairly successful in explaining the relaxation of small or simple 
molecules; however, it is insufficient for complicated multi-component structures, such 
as biological tissues. 
The FETS model suggests that tissues consist of two states of water: a large free 
water compartment, and a bound water compartment comprised of water molecules 
attached to the surface of the macromolecule. These two compartments undergo rapid 
exchange. The observed tissue T1 is then a weighted average of free and bound water[27], 



































The published relaxation data are consistent with the tissue T1 being determined 
primarily by the exchange between macromolecules and the bound hydration layer, while 
T2 is determined by the exchange diffusion between the bound water and the free 
water[27, 28]. 
1.3.2 Relaxation in tissue 
Relaxation is dependent on tissue type, species, frequency, temperature, as well as 
pathology[28] [29]. Table 1 is a summary of T1 and T2 relaxation times in human tissues 
measured in vivo at 37°C and 3T. 
 
Table 1.1. In vivo human tissue relaxation times from healthy volunteers 
 at 3T 
 
Tissue T1(ms) T2(ms) Reference 
White matter 1084±45 69±3 [29] 
Gray matter 1820±114 99±7 [29] 
Liver 812±64 42±3 [29] 
Heart 1471±31 47±11 [29] 
Kidney 1194±27 56±4 [29] 
Muscle 1420±38.1 31.7±1.9 [30] 
Cartilage 1240±107 36.9±3.81 [30] 
Synovial fluid 3620±320 767±48.8 [30] 
Marrow fat 365±9.0 133±6.14 [30] 
 
Both T1 and T2 vary extensively in different body tissues. Muscle and other organs 
have long T1s and short T2s, fat has a short T1 and a long T2, and fluid has a slow 
relaxation in both T1 and T2. The empirical fitting generates T1 frequency dependence as 
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, where A and B are tissue-dependent constants. T2 appears essentially 
independent of frequency in the MRI frequency range 1-100 Hz [28]. 
Relaxation changes in pathological tissues primarily due to the changes in tissue 
components, including alterations in the proportions of the components, changes in 
structural and its constituents. For instance, with edema, white matter T2 may be 
elongated because of the formation of intramyelin vacuole[31]; peripheral nerve system 
(PNS) disease causes demyelination, reducing the short T2 component and consequently 
the overall T2 may increase[32]. Malignant tumors result in “less ordered” (i.e., higher 
motion frequency) tissue water, and thus, a longer T1 [33]. Atherosclerosis deposits lipid 
(low relaxation times), fibrosis, and calcium (dephasing local water molecule faster), and 
may therefore yield a lower T1, T2, and PD[34]. 
1.3.3 Conventional methods of measuring the relaxation times  
 In this section, two conventional methods of measuring T1 and T2 are introduced. 
They always serve as gold standard T1 and T2 mapping methods, although many more 
efficient novel techniques have been developed.  
 1.3.3.1 Spin-echo T2 measurement 
The spins produce a FID signal after an excitation that tips them into the transverse 
plane. FID decays with a decay constant called T2*, which is much shorter than T2. The 
T2* dephasing is caused by the external B0 field inhomogeneity, in additional to the 
dipole-dipole interaction. To measure the intrinsic T2, the “spin echo” (SE) sequence was 





Fig 1. 4 (a) The spin echo pulse sequence diagram. First, a 90° excitation pulse is 
applied along the x’ axis. After a certain time period τ, a 180° “refocusing” pulse, is 
applied along the y’ axis. This refocusing pulse will invert the accumulated phase to the 
opposite direction in the x’-y’ plane. Thus, at time 2τ, the spins will “rephase” and create 
an “echo” signal. The echo time is called “TE.” The corresponding signal is plotted in (b). 
The FID follows T
2
* decay, but the spin echo amplitude is determined by T
2
. Fig 1.4 is 
from [23]. 
To improve the accuracy and efficiency of the T2 mapping, some variations of spin 
echo sequences have been developed. One well-known sequence is called the Carr-
Purcell-Meiboom-Gill (CPMG) [35]. This sequence adds a train of equally spaced 
refocusing pulses after excitation. It is considered to be the most accurate T2 
measurement and is used as the gold standard method for measuring T2 in this thesis. 
1.3.3.2 Partial saturation T1 measurement 
To acquire data for the full image k-space, a pulse sequence is repeated with a 
repetition time (TR). If TR is comparable to or shorter than T1, the excited spins will not 
reach their equilibrium before the next excitation. If TR>>T2, there will be no transverse 
signal left at the end of each TR. If M- is the Mz just prior to the excitation, and M
+ is the 
Mz after excitation, then, M




state, with constant M- and M+. At the steady state, substituting time t = TR in [1.9], with 
Mz(TR) = M
- and Mz(0) = M
+ = M-cosθ, M- can be solved as 
   [1.14] 
where E1=exp(-TR/T1). 
Suppose the system is in the steady state, and the signal readout occurs shortly after 
excitation such that, there is negligible signal decay in the transverse plane. Then the 
signal amplitude is M-sinθ, which may be acquired as a function of T1. By acquiring 
images with variable TRs, T1 and M0 are thus solvable with the known FA. When FA 
θ=90°, this T1 measuring method is called “Partial Saturation (PS)”, and is used as a gold 
standard in this thesis. 
Many other fast and efficient methods of measuring T1 and T2 have been published 
recently. Those methods will be discussed and compared in the following chapters as 
well. 
1.4 Contrast Maximization in MRI 
In this section, the contrast mechanism in MR images is introduced. The effect of T1, 
T2 and PD on image contrast and the relationship between contrast-to-noise ratio (CNR) 
and visibility are discussed. The concept of contrast agents is also briefly described. 
1.3.1 MRI contrast 
SNR and CNR are two important metrics with which to evaluate the quality of 
medical images. SNR measures the signal relative to the noise generated by random 
voltage fluctuation from the hardware and from the sample. CNR measures how much 
M - =
M0(1- E1)
1- E 1 cosq
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the signal from diseased tissue differs from that of normal tissue also relative to the noise. 
The CNR between two tissues A and B is defined as , 
where SA and SB are the voxel signal amplitudes from the two tissues, σ0 refers to the 
standard deviation (SD) of noise. 
How much CNR is needed for disease detection? According to the Rose Criterion, 
based on empirical exams, observers are able to detect objects in the image with an SNR 
threshold of 3-5 [36]. We can apply similar criteria to the CNR. Suppose SA and SB 
follow Gaussian distributions with the same SD and CNR=4, it can be shown that the 
probability of the observer to make an error in tissue detection is less than 2.5%[23]. 
As we know, the contrast of almost all MR images is governed by T1, T2, and PD. 
Signals acquired using different sequences follow different formulas containing the three 
parameters in accordance with the solution of the Bloch equation [1.3]. Here, we focus on 
a wildly used sequence called the gradient echo (GRE) as an example for understanding 
the contrast expression. The GRE sequence refocuses the dephased spins by applying a 
reverse gradient to form an echo. The GRE signal decay follows T2*. Assuming 
TR>>T2*, the contrast CAB between SA and SB in a GRE image thus becomes 
   [1.15] 
Thus, CAB can be optimized by suitable choice of TR or TE or both. 
1.3.2 Contrast maximization 
Tissue contrast in MRI can result from the differences in some or all of T1, T2, and 
PD. Here, three basic forms of MRI contrast are introduced: T1-weighted; T2 (or T2*)-
weighted; and PD-weighted contrast. PD measures the proton density, T1 is powerful in 
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To create a PD-weighted image, it is necessary to minimize the signal dependence 
on T1 and T2. Intuitively, spins should reach their equilibrium at the end of each TR 
cycle, which would eliminate the T1-weighting. In addition, the signal should be acquired 
shortly after excitation to eliminate T2 decay, i.e., TR>>T1 and TE<<T2*. In this case, 
[1.15] becomes . 
Similarly, to yield a T1-weighted image, the T2 weighting should be minimized by 
reducing TE to <<T2. A short TR that is comparable to T1, can be used to enhance T1 
contrast. To acquire T2- or T2*-weighted images, TR is generally set to >>T1, and TE 
kept comparable to T2. However, in T1- and T2-weighted images, the PD dependence 
generally cannot be eliminated. 
  In pure T1- (or T2-) weighted images, to optimize the contrast between two specific 
tissues, TR (or TE) should be calculated carefully by substituting the T1 (or T2) values 
and PD values into Eq. [1.15] and finding the maxima. In a more general case, the 
optimum contrast is achieved in an image that optimizes all three weightings of T1, T2, 
PD, with both TR and TE being solved simultaneously. In other words, if there is a 3D 
coordinate system with each axis corresponds to one of these parameters, we want to find 
a hyper plane in the space to separate two (or more) different tissues. The normal 
direction of that plane indicates the combination of the three contrasts (T1, T2, PD) with 
which the two (or more) tissues can be most clearly separated, to achieve maximum 
contrast. 
1.3.3 Contrast enhancement with a contrast agent 
For a tissue of interest that has T1, T2 and PD very close to those of the surrounding 
tissue, or that is too small to identify due to the MRI spatial resolution, a contrast agent 
(CA) is often introduced to improve visibility. A CA can be directly injected into the 
CAB » M0A -M0B
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body intravascularly or interstitially, or used as a label that binds to a target molecules’ 
surface[40]. 
Based on the magnetic properties and image effects, CAs can be classified into 
several major classes: paramagnetic CAs, superparamagnetic CAs, “heteronuclear” CAs, 
etc. Paramagnetic CAs, such as gadolinium (Gd3+) and manganese (Mn2+), possess one or 
more unpaired electrons, resulting in a strong magnetic moment, thousands of times 
larger than that of water molecule protons. The magnetic dipole interaction between the 
CAs and surrounding protons will expedite relaxation, and thus, reduce the T1 of the 
water protons, causing a signal increase in the T1-weighted image.  
Superparamagnetic CAs are often referred to as small superparamagnetic iron oxide 
(SPIO). They consist of very small magnetic crystallites. These crystallites have much 
larger magnetic moments than paramagnetic CAs. They produce a highly-localized 
magnetic field gradients, which cause a rapid T2 decay. Hence, SPIOs result in dark areas 
at target sites in T2-weighted MRI. In cell-tracking, SPIO particles have been most 
widely used. However, the reduced signal can always be confused with other attenuation 
effects, such as the iron in blood or blood clots[41]. It also induces strong field distortion 
to the underlying MR anatomy. Moreover, CAs that generate positive signals are 
preferable for cell visibility.  
Recently, 19F-based labeling probes have been developed as heteronuclear CAs. Due 
to the near non-existence of naturally abundant 19F in native mammalian bodies, cells 
labeled as 19F nuclei will be visible in 19F MRI with no background signal from the tissue. 
The 19F signal strength is directly proportional to the number of 19F nuclei present in the 
label, which also enables cell number quantification[3].
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Chapter 2.  Measuring and Imaging T2 using Dual-τ Method 




The transverse component of the nuclear magnetization can undergo T2 decay 
even during excitation. The T2 decay depends on the pulse length τ. Here, this property is 
exploited in a new, “Dual-τ” method of measuring T2 using the ratio of NMR signals 
acquired with short and long-duration excitations, using self-refocusing adiabatic pulses. 
This method uses no SEs. The Dual-τ method is implemented with B1-insensitive rotation 
(BIR-4) pulses, and validated theoretically with Bloch Equation simulations independent 
of FA, and experimentally in phantoms. Dual-τ T2 measurements are most accurate at 
short T2 where results agree with standard spin-echo measures to within 10% for 
T2≤100ms. Dual-τ MRI performed with a long 0° BIR-4 pre-pulse provides quantitative 
T2 imaging of phantoms and humans while preserving desirable contrast and functional 
properties of the rest of the MRI sequence. A single 0° BIR-4 pre-pulse can provide T2 
contrast-weighted MRI and serve as a “T2-prep” sequence with a lower B1 requirement 
than prior approaches. Finally, a Dual-τ-dual-FA experiment is introduced in which both 
τ and flip-angle are varied, enabling measurement of T2, T1 and signal intensity in just 
three acquisitions if flip-angles are well-characterized. These new methods can 
potentially save time and simplify relaxation measurements and/or contrast-weighted 
NMR and MRI. 
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2.1.1 Adiabatic pulse 
The term adiabatic as applied to NMR excitation pulses refers to frequency 
and/or amplitude modulated pulses whose effective B1-field in the frame-of-reference 
rotating at the Larmor frequency change sufficiently slowly such that the nuclear 
magnetization M is able to follow it without inducing transitions[42, 43]. Adiabatic 
pulses are highly-valued for their insensitivity to RF and B0 inhomogeneity over ranges 
determined by the pulse duration τ, flip-angle and B1 amplitude and frequency sweep 
(with maximum frequency, fmax) [44]. The duration of the pulses is supposed to be shorter 
than any relaxation processes–whence the term, fast passage. 
In the classic experiment, the frequency was swept linearly through resonance 
[42, 43]. Nowadays, adiabatic full-passage (AFP; 180°) and half passage (AHP; 
90°) pulses with B1(t) amplitude/frequency-sweeps that vary as sin/cos, tan/tanh and 
sech/tanh, offer far superior B1-performance [43-46]. The B1-insensive rotation (BIR-4) 
pulse, which combines four AHP segments, has further extended adiabaticity to flip-
angles that can be arbitrarily pre-set anywhere in the range |≤180° [47]. The BIR-4 
flip-angle is set by means of two phase-jumps between the segments, which can be 
phase-cycled to improve accuracy [48]. 
All of these pulses, and especially the BIR-4 pulses, are intrinsically longer than 
conventional hard pulses. To the extent that the magnetization M evolves in the 
transverse plane during the pulse, it is subject to transverse T2 decay, even when the 
pulses are self-refocusing [44, 49, 50]. This dependence is potentially exploitable for 
measuring T2, or for enhancing T2 contrast. To date, except for the use of spectral 
linewidths, T2 has been measured with NMR SEs. The most accurate T2 measurements 
are derived from the CPMG technique [35]. SEs are routinely used to provide critically 
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important T2-dependent contrast and T2 measurements in clinical diagnostic magnetic 
resonance imaging (MRI)[51]. 
Here we present a new approach for measuring T2 in NMR and MRI, and for 
providing T2 contrast in MRI, that does not use SEs. Instead, the T2 dependence of 
adiabatic pulses is harnessed to measure T2 by repeating the NMR or MRI acquisition 
sequence using one or more different adiabatic pulse lengths τ. We introduce the Dual-τ 
method, which provides a T2 measurement from the ratio of NMR signals acquired with 
short- and long-duration adiabatic pulses. This is analogous to the dual-angle method for 
measuring the T1 relaxation time from the ratio of signals acquired with two BIR-4 pulse 
flip-angles. Indeed, addition of a third acquisition permits the measurement of both T2 
and T1 using a combination of different pulse lengths and flip-angles in the Dual-τ-dual-
FA method, also introduced herein. Both the Dual-τ and the Dual-τ-dual-FA methods are 
implemented with self-refocusing BIR-4 pulses and validated by Bloch equation 
simulations, and by experimental studies of phantoms whose T2s and T1s are measured by 
standard CPMG SE and PS methods. The simulations provide a look-up table or curve 
which is used to convert measured signal ratios into T2 values. T1 is determined from a 
formula analogous to that used for the dual-angle method [52]. 
2.1.2 “T2 prep” 
Because adiabatic pulses are generally unsuitable for spatially-selective excitation 
in MRI, implementation of the Dual-τ method in imaging is most easily accomplished by 
addition of a 0° BIR-4 pre-pulse to the conventional MRI sequence. Since a 0° pulse does 
not otherwise affect the nuclear spin dynamics, other desirable MRI contrast and 
functional properties built into the sequence that follows the pre-pulse can be preserved. 
A single 0° BIR-4 pre-pulse of length τ can provide T2-contrast or T2-weighted MRI, as 
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well as “T2-prep” (T2-preparation) MRI with a lower B1 threshold than T2-prep 
sequences employing AHP and AFP pulses[53]. Quantitative Dual-τ T2 imaging can be 
performed by applying MRI sequences with and without the 0° τ pre-pulse. The Dual-τ 
T2 MRI method is validated with studies of phantoms and the human foot by comparison 
with standard CPMG methods. 
2.2 Theory 
2.2.1 Dual-τ Method 
The Mz and Mxy are affected by both T1 and T2 relaxation following a long 
adiabatic pulse [50]. At the end of an adiabatic pulse with FA= (time 0+), 
 and , as compared to the start of the 
pulse (time 0-). Here and are longitudinal and transverse attenuation factors, which 
are functions of τ, T2, B1 and the maximum frequency sweep, fmax, of the pulse, but not T1 
as long as τ<<T1. After self-refocusing at the end of the adiabatic pulse, the T2 decay can 
be written as , where g is a parameter reflecting the fraction of time spent by 
the magnetization in the transverse plane during the pulse. Numerical analysis of the 
Bloch equations for T2 ≤ 200ms with BIR-4 pulses of duration τ <40ms (see methods, 
below) shows that . We thus denote . 
If the residual transverse magnetization prior to time 0- is crushed [54], the 
steady-state magnetization after a sequence of adiabatic pulses applied at a TR 
comparable to T1 is [50]: 
;   [2.1] 
M z (0
+ ) = cosqM z(0
- )Ep
z M xy(0



































































where  and M0 is the equilibrium nuclear magnetization. If θ =90°, the 
application of two such sequences with the same TR but two different pulse durations τ1 
and τ2, will produce steady-state signals 
  and  .  
The ratio of these signals is: 
     [2.2] 
where Ep1 and Ep2 are the attenuation factors for the two pulses. Thus, R is just a function 
of T2 which can be derived numerically from the known B1 and fmax.   
2.2.2 Dual-τ-dual-FA T2 and T1 measurements 
The Dual-τ method is limited by the choice of θ =90° required to cancel the 
coefficient of Ep in the denominator of Eq. [2.1] for short TR. Incomplete cancellation 
can occur due to pulse imperfections, incomplete dephasing of residual transverse 
magnetization, and/or deviations in Ep as TR approaches T2. Achieving perfect 90° pulses 
is often problematic for in vivo applications such as MRI where the pulses are slice-
selective and the RF fields are seldom uniform across the slice. While increasing TR can 
alleviate this problem, long TRs generally reduce the SNR ratio per unit time and 
increase the scan time. We have overcome these limitations by adding a third acquisition 
to accommodate both θ<90° pulses and short TRs. Importantly, the additional acquisition 
can permit a simultaneous determination of T1 and T2. 
We call this the Dual-τ-dual-FA method, in which: 1) a first signal S1 is acquired 







M xy(t = t1) = M0(1-E1)Ep1

































signal S2 is excited by a β° adiabatic pulse of duration τ2; and 3) a third signal S3 is 
excited by a β˚ adiabatic pulse of length τ3=2τ2. The three steady-state signals are: 
,    and  [2.3]  
   
Using the same B1 and fmax for both adiabatic pulses yields , Ep3=Ep2
2, and the 
equation set simplifies to a quadratic: 
 ,  [2.4] 
where , , and 
. 
Choosing the root of Eq. [2.4] that falls in the interval (0, 1) yields the T2 attenuation 
factor 
   .       [2.5] 
Substitution of Eq. [2.5] into Eq. [2.3] yields the T1 attenuation factor 
or  [2.6] 
This is basically the dual-angle equation [52] with an Ep2-attenuation correction. Thus, 
from Ep2 and E1,  
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2.3.1 Numeric simulations 
Simulations of the Bloch equations were performed using Matlab (Mathworks, 
Natick, MA)[55]. The evolution of magnetization was simulated for proton (1H) 
relaxation at 3T over the range 20 ≤T2 ≤200ms and 0.1s ≤T1 ≤1s for BIR-4 pulses with 
B1=20µT and fmax =15kHz, as used in experiments. Pulses were defined at 5µs intervals 
with lengths varying from 1≤τ ≤40ms, a practical range given limitations in RF pulse 
power and power deposition. Adiabatic pulse flip-angles were varied from 0 ≤θ ≤90°. 
The simulations were used to derive the attenuation factors, and  after long BIR-4 
pulses, decay parameter g, and the corresponding signal ratio R, as a function of T2, T1, τ, 
and θ in the Dual-τ experiment. 
Monte Carlo simulations were performed to evaluate the sensitivity of Dual-τ and 
Dual-τ-dual-FA measurements, to noise. The SD of the noise was set at 2% of the signal 
strength (SNR=50) elicited by each pulse. The signals, their ratio R for the Dual-τ T2 
experiment, and the solutions to Eq. [2.7] for the Dual-τ-dual-FA experiment, were 
determined for 1000 simulations as a function of T2 up to 80ms in the Dual-τ and Dual-τ-
dual-FA experiments, and 0.1s≤T1≤1s for the Dual-τ-dual-FA experiment. Note that T2 
measured by the Dual-τ experiment is unaffected by TR for perfect θ =90° pulses. 
2.3.2 Phantom construction 
Twelve phantoms with tissue-comparable relaxation times were prepared with 
agarose (Type 1-A CAS 9012-36-3: Sigma Chemical, St. Louis, MO, USA) and CuSO4 
(CAS 7758-99-8: Acros organics, Geel, Belgium) in de-ionized distilled water. Both 
agarose and CuSO4 shorten the T1 and T2 of pure water. However, agarose decreases T2 






CuSO4 and agarose were adjusted from 0.2 to 1.6g/l and 10 to 110 g/l respectively, to 
provide phantoms with 10ms<T2<130ms, and 0.15s<T1<1.0s [56]. The ingredients were 
mixed in a beaker and heated in a microwave oven to dissolve the agarose without 
introducing too many bubbles. The hot solutions were then sealed to occupy 9cm of 
12cm- long, 25mm inner diameter (ID) plastic tubes and allowed to cool and gel. 
2.3.3 NMR measurements 
All NMR and MRI measurements were done on a 3T Achieva MRI scanner 
(Philips Healthcare, Best, The Netherlands) using the standard transmit/receive birdcage 
head coil (maximum B1=20µT). The gel phantoms were set in a plastic foam panel in the 
center of the coil with long axes parallel to the z-axis. To facilitate T1 and T2 
measurements, NMR data were acquired with one-dimensional chemical shift imaging 
(1D CSI, 5mm resolution; acquisitions per frame, NEX=1) from five aligned phantoms at 
a time. In all measurements involving BIR-4 pulses, the flip angles were calibrated at the 
pulse lengths being tested. Dual-τ T2 was measured with two 90° BIR-4 pulses of lengths 
τ1=5ms (fmax =12kHz) and τ2=35ms (fmax =15kHz), the shortest TE (1.8ms) and TR=4s.  
Reference T2 and T1 relaxation times were measured at 3T using standard SE and 
PS NMR methods, respectively. Individual SE data was obtained using 1D CSI with 8 
different echo times (TE=14, 30, 50, 75, 100, 150, 200, 300ms), and TR set to 4.0s to 
allow for complete signal recovery. T1 was measured using PS sequences with TR =0.25, 
0.5, 1, and 3s. Because relaxation times can change slowly over time, these 
measurements were repeated whenever a dual- or Dual-τ-dual-FA study was done. 
CSI yielded approximately 5 slices in the CSI direction from each phantom. The 
FID signals acquired from the three middle slices in each phantom were fitted using 
jMRUI software (available from www.mrui.uab.es)[57] to determine the peak areas. 
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These values were used to determine the signal ratio at the two τ values. Dual-τ T2 was 
then determined from a look-up curve generated by the numerical analysis (see Results 
mean±SD). Reference T1 and T2 measurements obtained by conventional SE and PS 
methods were determined from the same three slices by fitting the data sets to  
 and
 
 with u, v and w constants. Mean reference 
relaxation times from the phantoms used in the Dual-τ studies are listed in Table 2.1. 
 
Table 2.1 Numbered phantoms with their relaxation times for the Dual-τ T2 NMR 




1 2 3 4 5 6 7 8 9 10 11 12 
T2(ms)  110 97 65 65 52 44 35 28 18 13 106 67 
T1(ms) 818 837 770 740 691 702 665 635 567 582 825 - 
T2 was measured by a 32-points SE NMR method (TE stepped by 7.21ms). T1 was 
measured by PS NMR (0.1s≤TR≤1.5s). The signal within each phantom was first 
averaged then fit to an exponential relaxation curve. 
 
 
The Dual-τ-dual-FA method was also validated in 1DCSI studies of 12x1.3cm ID 
and 4x2.5cm ID phantoms with 169≤T1≤890ms and 31≤T2≤129ms. We used τ3 =2τ2 
=20ms, and TR=300ms for all experiments. Shorter TRs were limited by RF power 
restrictions. S1 was acquired with a (non-adiabatic) 75µs α-hard pulse nominally set to 
15°. The flip-angle was 14° for the short phantoms as determined from B1 field profiles 
measured separately, and 13.5° for the long phantom. The β-pulse used to acquire S2 and 
S3 was a 60° BIR-4 pulse. The choice of the nominal α =15° and β=60° pair for the Dual-
τ-dual-FA experiments was based on the dual-angle T1 method [52]. 
  2expw TE T    1expu v TR T  
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2.3.4 MRI measurements 
The BIR-4 pulse is unsuited to spatial localization. Thus for MRI applications, 
either multi-dimensional phase-encoding must be used (with generally unpalatable scan 
times), or the BIR-4 pulse must be applied in conjunction with an additional spatial 
localization pulse. We adopt the latter approach by adding a 0° BIR-4 pulse before the 
slice-selective pulse in a standard GRE MRI pulse sequence. This is based on numerical 
analysis showing that the effect on Ep of the BIR-4 pulse is independent of θ (see results).  
Dual-τ MRI was performed on the phantom set with a two-dimensional (2D) GRE 
MRI sequence and 0° BIR-4 pulses with the same τ, fmax and B1 used in the NMR 
experiments (acquisition matrix, 152 x154; field-of-view, FOV=97x10x230 mm3; slice 
thickness=10mm; TR=2s; minimum TE=2.5ms). The delay between the BIR-4 and (1ms) 
slice-selective pulses was 1.5ms. Because the excitation pulse and inter-pulse delay are 
unchanged in this Dual-τ MRI experiment, the same curve from the numerical analysis 
was used to obtain T2. The sequence timing diagram is shown in Fig 2.1. Reference T2 
values from conventional MRI were obtained from the phantoms using a 3D 32-echo 
sequence (TE step =7.21ms, TR=461ms, 2.5ms excitation pulse 1.5ms after the BIR-4 
pulse). T2 was measured in images by determining the ratio R on a pixel-by-pixel basis 
for the Dual-τ method, and by fitting the SE pixels to an exponential to obtain reference 





Fig 2.1 Timing diagram of a sequence employing one of 0° BIR-4 pre-pulses for the 
Dual-τ MRI method. In MRI experiments TE was set to a minimum (4.8ms), TR at 2s, 
and the gap between the pre- and excitation-pulses was ~1.5ms. 
 
Human studies for this project were approved by the Johns Hopkins Institutional 
Review Board. The foot was chosen based on the expected short T2s of muscle and 
cartilage [30], for which analysis showed the Dual-τ method to be well-suited. A healthy 
volunteer was positioned supine with the foot in the head coil, and Dual-τ T2 MRI 
performed using two acquisitions of a coronal 3D GRE sequence, one employing a 0° 
BIR-4 pre-pulse (matrix size, 112x112; slice thickness =6mm; FOV = 42x100x100 mm3, 
TR =2s, TE =4.1ms =minimum). Reference T2 MRI of the foot was performed with the 
32-echo sequence (same matrix, slice thickness and FOV as for Dual-τ GRE; TE step 
=5.39ms; TR=625ms). T2 images and average T2 values were calculated the same way as 
in the phantom studies. 
2.4 Results 
2.4.1 Numeric simulations 
The attenuation factor, Ep as a function of T2 is plotted in Fig 2.2 for four BIR-4 
pulses of duration 5-35ms. The curves all fit accurately to the exponential 
. In this case, g =0.81. This result is independent of flip-angle 









opposite phase-jumps of duration <<T2 and T1. In the adiabatic region wherein  is 
independent of B1, g is relatively insensitive to fmax , for example, varying by <4% for 
12kHz ≤ fmax ≤15kHz and B1=20µT. 
 
 
Fig 2.2 Numerical simulation of the attenuation factor EP=|M|/M0 after a BIR-4 pulse of 
duration 5ms (magenta), 15ms (green), 25ms (blue) and 35ms (black), as a function of 
T2 from 20 to 200ms (T1 =1s, TR = ∞ for complete longitudinal relaxation). The curves 
are exponential fits to stars are the numerically-determined points. 
 
The sensitivity and accuracy of the Dual-τ T2 experiment are improved by 
selecting BIR-4 pulses with very different pulse lengths, notwithstanding RF power 
constraints. Pulses shorter than 5ms have little attenuation but are limited by peak pulse 
power. Long pulses are limited by the RF power amplifier’s ability to sustain the pulse, 
as well as by the spectral bandwidth of the sample. The ratio of the signals from the 
τ1=5ms and τ2=35ms pulses is plotted in Fig 2.3(a). The curve is fit by 
 independent of θ. Sensitivity is maximum over the steepest 
(short-T2) region of the curve, with the τ1/τ2 =5/35ms pair providing reasonable T2 
resolution up to 70 or 80ms. Thus, T2 can be read from Fig. 2.3(a) using the measured 
signal ratio. The variation in T2 determined from the ratio curve is plotted as a function of 
R(T2 )= exp(-24.3 /T2 )
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Fig 2.3(a) Computed ratio R of two signals acquired with adiabatic pulses of length τ=5 
and 35ms as a function of T2.  The curve has the form R(T2)=exp(-24.3/T2). (b) Dual-τ T2 
determined from part (a) as a function of T1 (red, T1=0.2s; green, T1=0.6s; blue, 
T1=1.0s). The result is independent of TR. 
 
The results of the Monte Carlo simulations are exemplified in Fig. 2.4.  For the 
Dual-τ T2 experiment performed with τ1/τ2 =5/35ms pulses and signals with 2% SD, the 
errors are essentially independent of TR for 0.1s ≤TR ≤1.0s. Over this range, the mean 
error in T2 is less than 6% ±9%(SD) of T2 for T2≤80ms and 0.3s≤T1≤1s (Fig. 2.4a). On 
the other hand, the simulated Dual-τ-dual-FA experiment with τ3=2τ2=20ms is less 
accurate on average, with a mean error varying from -13% to +6% of T2 (with up to 
±30% SD scatter) for T2≤80ms over the ranges 0.1s ≤TR ≤1.0s and 0.1≤T1≤1s (Fig. 
2.4b). When τ3 is set to 35ms–the same as τ2 in the Dual-τ experiment–the mean error 
decreases to <13% ±17%(SD) of T2 for the same T1s and TRs (eg, Fig. 2.4c). 
The accuracy of T1 in the Monte Carlo simulations of the Dual-τ-dual-FA 
experiment is better than 1% of T1 with a 9-15%(SD) scatter, essentially independent of 
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pulse length for 0.3≤T1≤1s and 30≤T2 ≤130ms, as shown in Fig. 2.4(d) for TR=0.3s. At 
shorter T1s (<TR), the scatter in T1 increases as the long TR becomes sub-optimal for 
measuring T1 [8]. Then, reducing TR to 0.1s, reduces the scatter back to 9-15% of T1 for 
0.1≤T1≤1.0s. 
 
Fig 2.4 Monte Carlo simulations of the error in (a) Dual-τ T2 with τ  =5ms and τ  =35ms; 
(b) Dual-τ-dual-FA T2 with τ3=2τ2=20ms; and (c) with τ3=2τ2=35ms; and (d) Dual-τ-dual-
FA T1 with τ3=2τ2=20ms, T2=40ms, and TR=300ms. Points are means ±SD for a 2% 
root-mean-square noise in each signal measurement (SNR=50) from 1000 runs with 
T1=1s. The mean and SD of the T1 measured by a Dual-τ-dual-FA experiment with 
τ3=2τ2=35ms differs from (d) by less than 1%. 
 
2.4.2 Experiments 
Results from the 1H 1D CSI Dual-τ validation experiments on the 10 phantoms 
are plotted in Fig. 2.5. The T1 of these phantoms was 0.6–0.8s (Table 2.1). The T2s were 
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determined from Fig. 2.3. Below T2=70 ms, Dual-τ T2 values differ from SE values by 
≤3%.  
Dual-τ T2-weighted and T2-image results from the phantoms are shown in Fig 2.6. 
The phantoms are labeled with the corresponding average T2 values measured by 
standard 32-echo SE MRI (Fig. 2.6a), and by Dual-τ MRI (Fig. 2.6b). The T2 values 
agree with the SE results within 5% up to 70ms, and 10% up to 100ms. Dual-τ and 
standard SE T2 MRI of the foot are compared in Fig 2.7. Muscle T2 values from the Dual-
τ image are 29.4±1.2ms, 28.2±1.6ms, and 30.6±1.3ms; as compared to 29.8±2.8ms, 
29.8±4.7ms, and 28.8±4.7ms in the same annotated volumes in the SE image. These 
agree with published values for muscle of 32±2ms at 3T.[30]. In marrow, SE T2 was 
106±4.3ms as compared to Dual-τ T2 = 135±13ms in the same volume, and a published 
value of 133±6ms for marrow[30]. 
T2 and T1 values measured from the Dual-τ-dual-FA experiments on phantoms are 
compared with SE and PS T1 and T2 values in Fig. 2.8. The values show good agreement 
for all phantoms. 
 
Fig 2.5(a) Transverse image of 5 of the phantoms annotated with 5mm thick 1DCSI 
slices (annotated in red). (b) NMR measurements of T2 from the 10 phantoms using 
Dual-τ and SE methods. Filled points are the means of the middle three slices of each 
phantom. Error bars denote ±SD. 
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Fig 2.6(a) MRI of the phantom set, T2-weighed by a 0° 35ms BIR-4 pre-pulse. The 
images are annotated with the corresponding reference SE T2. (b) Color-coded Dual-τ T2 
image with the Dual-τ T2 values labeled for comparison with part (a).The scale depicts T2 
in ms. The T2 map is calculated pixel by pixel, and both images masked at the same 




Fig 2.7 Coronal T2 images of the human foot by the SE method (a) and the Dual-τ 
method (b). The scale depicts T2 in ms. Both images are calculated pixel-by-pixel and 
masked by an identical threshold (SNR =4 in the raw image). Mean T2s from the 
annoted squares in (a) vs (b) are: A, 29.8 ±2.8ms vs 29.4±1.2ms; B: 106 ±4.3ms vs 135 
±13ms; C: 29.8±4.7ms vs 28.2±1.6ms; D: 28.8±4.7ms vs 30.6±1.3ms. 
 
 
Fig 2.8 T2 and T1 as measured by a τ3=2τ2=20ms Dual-τ-dual-FA experiment from 
12x1.3cm ID (empty points) and 4x2.5cm ID (filled points) phantoms, as compared with 
values measured using standard SE (a) and PS (b) methods (solid line =identity). 
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2.5 Discussion  
Long adiabatic pulses such as BIR-4 are self-refocusing but are subject to T2 decay, 
resulting in attenuation by the end of the pulse. We have shown for the first time that T2 
measurements and T2 image contrast can be obtained using these adiabatic pulse 
properties as distinct from conventional methods that use spin-echoes or 180° refocusing 
pulses. In particular, we have presented new NMR and MRI pulse sequences for 
measuring and imaging T2 that can be performed in just two acquisitions employing long 
and short duration adiabatic pulses for NMR, or a long and no adiabatic pulse for MRI. 
These Dual-τ methods were validated with BIR-4 pulses by numerical analysis of the 
Bloch Equations, and experimentally by 1H NMR and MRI studies of phantoms of 
different T2s and MRI of the human foot, as compared with conventional SE T2 
measurements as the reference standard (Figs. 2.4-2.6). Moreover, extension of the Dual-
τ to the Dual-τ-dual-FA method resulted in a technique that not only delivered T2 
measurements but T1 as well. The Dual-τ-dual-FA method was also validated by both 
simulations (Fig. 2.4) and experimental measurements on phantoms (Fig. 2.8). 
As with existing techniques for measuring relaxation times, the Dual-τ and Dual-
τ-dual-FA methods can be adversely affected by B1-field nonuniformity when the 
adiabatic pulses are combined with conventional pulses such as those provided by MRI 
sequences (Fig. 2.1). The combined effect of an imperfect slice profile and B1 
inhomogeneity–to which higher-field MRI systems are intrinsically more susceptible–is 
significant. In order to cancel the denominator in Eq. [2.1] and obtain a ratio R from 
which T2 can be determined using the Dual-τ method, we must have either = 90° or a 
long TR. Obtaining an exact = 90° slice-selective excitation pulse at 3T depends on the 
accuracy of the scanner’s set-up routine. Our Dual-τ MRI studies of the foot benefited 
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from the use of a 3D (slab-select) pulse sequence for both the Dual-τ and reference SE 
MRI, selection of just the middle slices, and a longer TR than we would have liked 
because of the uncertainty about the 90° pulse. 
The delays of several milli-seconds added between the 0° BIR-4 pulse, the 
slice-selective pulse and the echo-times for the MRI sequences, will affect the total 
attenuation factor, reducing the SNR a little. This does not seem to affect T2 in the Dual-τ 
MRI experiment where the delay is the same in both cases. Although the S1 acquisition of 
the Dual-τ-dual-FA experiment does not have a delay while the S2 and S3 acquisitions do, 
the Dual-τ-dual-FA T2 accuracy is also apparently unaffected. 
The accuracy of T1s measured in the Dual-τ-dual-FA NMR experiment depends 
critically on the accuracy of the low-angle non-adiabatic 15° NMR excitation pulses set 
by the scanner [52] when non-adiabatic pulses are used. If MRI is not intended, an 
adiabatic 15° pulse could avoid this problem provided its duration is <<τ2 to avoid a 
significant 3rd Ep1 term in Eq [2.3]. Meanwhile, the accuracy of T1 imaging using a Dual-
τ-dual-FA MRI sequence wherein the 60° BIR-4 pulses are replaced by 0° BIR-4 or 
BIRP pulses plus nominally-60° slice-selective pulses for S2 and S3 with a 15° slice-
selective pulse for S1, depends on the accuracy with which B1 and/or the flip-angles are 
calibrated. Nevertheless, the Dual-τ-dual-FA pulse sequence is presently unique in 
demonstrating a potential for measuring and imaging T1, T2 and proton density from just 
3 (albeit steady-state) acquisitions–all of which are FIDs, at that.  
That the decay in magnetization during the BIR-4 pulse is essentially independent 
of the flip-angle enables decoupling of T2 from the flip-angle, to the point of being able 
to provide a T2 attenuation effect with otherwise zero excitation. In this application, the 
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0° BIR-4 pulse serves as a T2 filter, removing the short T2 components (Fig. 2.6a), while 
preserving the longer ones for an FID generated by a subsequent conventional excitation. 
This could be useful in spectroscopy for removing unwanted short-T2 components that 
generate broad baselines. Also, the use of pre-pulses to add T2 contrast bears similarity to 
T2-prep MRI sequences, especially those employing adiabatic pulses[53]. Adiabatic T2-
prep MRI uses several very short 90° AHP and 180° AFP components with gaps between 
them to allow T2 relaxation[53]. By using a (i) single, (ii) long, (iii) 0° BIR-4 or BIRP 
pulse, (iv) with no gaps, our sequence differs from this T2-prep sequence in four ways. 
Moreover, the present work extends the application from providing T2 contrast, to 
providing T2 measurements. 
Conversely, the use of a single long 0° BIR-4 pulse instead of the short AHP/AFP 
pulses of the T2-prep sequence[53] may offer some advantage. The single long BIR-4 (or 
BIRP) pulse has a much lower B1-threshold to achieve adiabaticity than the short AHP 
and AFP pulses. As a consequence, it requires much lower peak power. For example, the 
simulations of a 45ms AHP/AFP T2-prep sequence from Fig. 2.4a of Ref. [53]showed an 
adiabatic threshold requirement for B1 of about 20µT. Performing the same simulation 
with the same T1 and T2 here, shows that use of a 45ms 0° BIR-4 pre-pulse results in a B1 
threshold that is approximately 5µT, or 1/4 that of the adiabatic T2-prep sequence, as 
shown in Fig 2.9. 
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Fig 2.9 Contour plot of Mz/Mequ (scale at right) as a function of off-resonance frequency 
using a 45ms 0° BIR-4,T1=1115ms, and T2=55ms, for comparison with the 45ms T2-prep 
sequence in Ref. [53]. 
 
Another question is whether the Dual-τ experiment with long adiabatic pulses 
measures either the inhomogeneously broadened T2 (T2*) or the T1 in the rotating frame 
(T1), as distinct from a pure T2. First, T2* results from local B0–field inhomogeneity or 
offset frequency, to which a BIR-4 pulse operating above its adiabatic threshold is 
insensitive over a range of several hundred Hz[52]. In the present studies, analysis shows 
T2 varies by less than 6.5% for offset frequencies in the range ±300Hz, 30ms≤T2≤130ms 
and TR=T1=1s, in our commercial 3T birdcage head-coil with B1 of 20µT. Second, T1 
measures T1 at the much lower NMR frequency corresponding to the B1 field. Although 
it is not explicitly present in the Bloch Equations, T1 approaches T2 as B1 goes to zero, 
and behaves like a combination of low-frequency T1 and T2 [58]. As such, changes in T1 
might be expected to affect Dual-τ T2 if it were sensitive to T1. However, analysis of the 
Dual-τ experiment showed variations <6% in T2 over a 5-fold range of T1 (Fig. 2.3b). In 
experiments, Dual-τ T2 measured at a B1 of 13.5µT (knee coil) did not differ by more 
than 3% from those measured with B1 =20µT (head coil) on the same short- and long-T2 
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phantoms. Thus, T2* and T1do not appear to be significant factors affecting Dual-τ T2 
measurements in this work. 
In conclusion, the Dual-τ method provides a new option for measuring T2 without 
requiring any spin echoes, at least for short T2 tissues such as muscle, cartilage and white 
matter [59] where the signal ratio affords adequate T2 resolution (Fig 2.3a). The same 
property delivered with an otherwise neutral 0° flip-angle self-refocusing adiabatic pulse 
can provide T2-imaging, T2-weighting, T2-filtering (Figs. 2.6, 2.7), or T2-prep (Fig. 2.9). 
At the expense of one additional acquisition, the Dual-τ-dual-FA experiment offers the 
potential for obtaining all of the T2, T1 and proton or signal density information with just 
three acquisitions–arguably the minimum possible–with the caveat that it requires 
accurate setting and knowledge of the flip-angles. These new methods can potentially 





Chapter 3.  Minimum Acquisition Methods for Simultaneously 




The 1H T2, and T1 relaxation times of water and PD in healthy, diseased and 
treated biological tissue, are fundamentally responsible for image contrast and the success 
of MRI in medicine and biology. Nevertheless, the explicit imaging of T1, T2, and PD is 
rarely performed in clinical MRI exams, due to confounding factors affecting accuracy 
and to scan-time limitations. Indeed, the imaging of T1, T2, and PD is routinely 
supplanted by proxies such as T1- and T2-weighted image intensities. As a result, MRI 
scanner settings, being empirically derived, may not be optimized for contrast and 
detecting a particular disorder. Moreover, image intensities recorded at different MRI 
centers are generally not quantitatively comparable, and much potentially diagnostic T1 
and T2 information, is simply not collected. 
This is not to say that no efficient MRI relaxometry methods for jointly imaging 
T1, T2 and PD are available. Six such methods are compared in Table 3.1. Of these, those 
employing steady-state free-precession (SSFP) sequences (eg, “DESPOT1” and 
“DESPOT2”[60], “TrueFISP” T1 and T2[61], and “TESS”[62]) are acutely sensitive to 
non-uniformity in both the B0 and the B1. Such non-uniformities tend to increase with B0. 
Although the short SSFP sequence TR saves time, the effect of B1 errors in the excitation 
FA accumulates faster than in long-TR sequences, necessitating careful B1 calibration. 
Short-TR SSFP is also prone to magnetization transfer (MT) errors[63]. The “FARM” 
method[64] (based on the “Look-locker” approach[65]), the inversion-recovery (IR) 
TrueFISP[61], and the IR-snapshot FLASH[66] methods sample the transient T1 recovery 
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curve, with acquisition strategies that can be optimized to minimize scan-time[67]. The 
latest “MR fingerprinting” (MRF) technique[68] also provides T1, T2, and PD imaging 
capabilities based on a look-up table of solutions to the Bloch equations obtained by 
numerical simulation. Accommodations in the modeling for the effects of non-uniform 
B1, off-resonance, and T2* in the absence of spin-echoes, are anticipated to be important 
for the accuracy of those results as well. For all approaches, the central requirements are 
that T1- and T2-dependence be imposed on the MRI signal; that this dependence be varied 
in repeat applications of the MRI pulse sequence; and that the resultant T1, T2 and/or PD-
dependence can be separately deciphered from the resultant signals, thereby enabling the 
corresponding parametric images to be reconstructed. 
Recently, we reported that self-refocusing BIR-4 adiabatic pulses[47, 49] are 
prone to intra-pulse T2 decay that depends on the , B1 amplitude, and fmax of the pulse 
[50]. This results from the time spent by the magnetization in the transverse plane during 
excitation[44]. Importantly, the T2 decay is independent of the FA, which can be 
arbitrarily chosen for these pulses[47]. As a consequence, T2-dependent attenuation of 
MRI signals is achievable simply by adding a long 0° BIR-4 pre-pulse to the MRI pulse 
sequence, leaving the sequence’s other excitation properties substantially unaffected[69]. 
With this ‘dual-τ’ T2 MRI method[69], T2 maps were obtained without SEs, from the 
ratio of two steady-state signals acquired with two different pulse lengths but the same 
TRs. This chapter explores MRI methods that utilize this feature to image T2, T1, and PD 
in just three steady-state acquisitions, or four acquisitions if self-correction for 
inhomogeneity in the RF excitation field (B1) is included. This is the minimum number of 
acquisitions possible. 
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Table 3.1 Summary of common methods for measuring T1, T2, and M0. The techniques 























T1, T2, PD Transient >38 short(<6ms) SSFP Assumes 
uniform B1, 
B0.  
FARM[64] T1 only Transient 2 short(6ms) SPGR Sensitive to 
FA errors 
TESS[62] T1, T2 SS 3 21ms SSFP T1 sensitive 
to B1 errors 
MRF[68] T1, T2, M0 Transient 1000 10-15ms SSFP Requires 
knowledge of 




T1, T2 and 
PD 






T1, T2 and 
PD 





Four FA T1, T2, PD 
and FA 
SS 4 600ms SPGR B1 self-
correction.  
 
The T1 information can be encoded into a ‘dual-τ’ T2 MRI experiment by varying 
either the excitation FA[52, 70] or the TR [71] of the pulse sequence. This yields PD as 
well, but normally requires at least two more acquisitions, for a total of four. To image all 
three parameters–T1, T2, and PD–in three acquisitions, requires that both τ and either of 
TR or FA each be varied in at least two of the three acquisitions. Of these two options, 
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we first evaluate the ‘Dual-τ Dual-FA’ method wherein TR is kept constant and a GRE 
MRI sequence is applied once with a small FA pulse, and twice more with the same large 
FA pulse, but preceded by either a short or a long 0° adiabatic pre-pulse. Next, the ‘Dual-
τ Dual-TR’ experiment with a constant FA is evaluated. Here, a first MRI sequence is 
applied with a short adiabatic pre-pulse and a short TR; a second sequence is applied with 
a short 0° adiabatic pre-pulse and a long TR; and a third sequence uses both a long 0° 
adiabatic pre-pulse, and a long TR. 
As with conventional methods for measuring T1, precise knowledge of the local 
FA is essential for accuracy. This means that both the ‘Dual-τ Dual-FA’ and ‘Dual-τ 
Dual-TR’ methods would effectively require at least two additional MRI acquisitions to 
map B1. While the standard B1 mapping software on clinical scanners is well-suited to 
providing FA information for 3D MRI, correction for trans-slice B1 (FA) variations in 2D 
MRI requires repeat acquisitions to individually calibrate each sequence when the errors 
are T1-, TR-, and FA-dependent[72]. Therefore, in the final method evaluated here, the 
spatial FA variation is recognized as integral to a complete T1, T2, and PD MRI 
experiment. We add just one acquisition to the ‘Dual-τ Dual-FA’ method to create the 
‘Four-FA’ experiment which yields T1, T2, PD and FA (or B1) in just 4 acquisitions. The 
FA and T1 information is extracted from GRE signals acquired with three different FAs 
plus a short 0° adiabatic pre-pulse, while a long 0° adiabatic pre-pulse in the fourth 
acquisition yields T2. All three methods are validated in vitro, and the ‘Dual-τ Dual-FA’ 
and ‘Four-FA’ experiments are also demonstrated in human brain studies in vivo at 3T. 
In what follows, we first describe how T2 is encoded for all three methods using 
long adiabatic pulses. To avoid confusion, each method is then presented serially with its 
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own theory, experiment, and results section. Finally, the efficiency, accuracy, and 
efficiency per unit accuracy are compared in Monte Carlo simulations of the ‘Four-FA’ 
method with a combined PS plus SE experiment, and with the DESPOT1/2[60], IR 
TrueFISP[61], and MRF methods.  
 
3.2 Dual-τ Dual-FA Method  
3.2.1 Theory 
The derivation of the ‘Dual-τ Dual-FA’ method has been discussed in Chapter 2. 
It is a single steady-state acquisition is added to the dual-τ T2 experiment to encode T1. 
Here we will extend the NMR validation of this method to a full scope quantification 
evaluation including numerical simulations, in vivo and in vitro MRI measurements, and 
comparison with other quantification methods.  
The three acquisitions use the same TR, but are applied with two different 
excitation FAs,  and β. This part of the experiment is analogous to the dual-angle T1 
method[52] where α=15º and β=60º were found to yield both useful T1-sensitivity and 
SNR. 
The ‘Dual-τ Dual-FA’ acquisitions specifically comprise: (A1) a first signal S1 
excited by a conventional GRE MRI sequence with a short-α RF excitation pulse. In step 
(A2), a second signal S2, is excited by a 0° adiabatic pulse of duration τ2, followed by a 
GRE sequence with a FA of β >α excitation pulse.  A third signal S3, is excited in step 
(A3) by a 0° adiabatic pulse of duration τ3=2τ2 followed by a GRE sequence, also with 
FA=β. As noted above, adding a short (eg, 1ms) 0° adiabatic pre-pulse in step A1, is 
prudent to control for the effects of the delay between the pre-pulse and signal acquisition 
in steps A2 and A3. 
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3.2.2 Methods 
3.2.2.1 Numeric simulations 
Monte Carlo simulations of the nuclear magnetization were performed to 
determine the sensitivity of the relaxation measurements to noise. The simulations were 
performed by numerical analysis of the Bloch equations using Matlab software 
(Mathworks, Natick, MA)[55] with the SD of the noise set at 2% of the signal strength 
for each sequence. The mean and SD (T1) of the solution for T1 was determined from 
100 runs for 0.3≤T1≤1.5s with T2=80ms as a function of TR, setting α=15º and β=60º as 
in the dual-angle method[52]. The mean and T2 for T2 was determined with T1=1s for 
0≤T2≤80ms. The adiabatic BIR-4 pulse length was set to τ3=2τ2=20ms, with B1=13.5µT, 
and fmax=5kHz (frequency sweep) to be consistent with the use of a Philips 3T MRI 
scanner’s body coil for excitation during validation experiments. 
3.2.2.2 MRI validations on phantoms and human brain 
A four-compartment phantom comprised of tubes with T1 and T2 values spanning 
that of brain matter (640 ≤T1 ≤1285ms and 35 ≤T2 ≤191ms) was prepared for in vitro 
validation studies, using agarose and CuSO4 solutions as described in Chapter 2[56]. 
Their relaxation values were determined by standard PS and SE methods as detailed 
below. In vivo validation was performed in brain studies of healthy volunteers approved 
by the Johns Hopkins Institutional Review Board (IRB). Subjects were positioned supine 
and T1 and T2 measured by standard 3D PS and SE methods for comparison with ‘Dual-τ 
Dual-FA’ measurements. 
All MRI was done on a Philips 3T Achieva MRI scanner (Philips Healthcare, 
Cleveland OH). The BIR-4 pulse FA was calibrated by ensuring a minimum signal at 
FA=0° for the pulse-lengths used[73]. The ‘Dual-τ Dual-FA’ method was validated using 
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a Philips 8-channel SENSE receive-only head coil, with body coil excitation, and BIR-4 
pulse parameters as simulated in Sec. 3.2. Under these conditions, the scanner’s RF 
power constraints limited TR to ≥609ms for acquisitions employing 20ms BIR-4 pulses. 
Standard 3D PS T1 and SE T2 values were measured in every validation 
experiment to avoid any confounding temporal variations in T1 and T2. The same MRI 
spatial resolution, FOV, and bandwidth (BW) were used for each T1, T2, PD, and B1 
mapping method being compared. The PS method employed a slab-selective 3D GRE 
sequence with TR=100, 300, 600, 900, 1200, 2000ms in vitro with FA=90°. The 3D SE 
method used 32 spin-echoes with TR/TE=1200/10ms. PS T1 and SE T2 values were 
calculated on a pixel-by-pixel basis using a nonlinear least-squares fit of the signal to the 
relaxation curves [w.exp(-TE/T2)+z] and [u-v.exp(-TR/T1)], respectively, with u,v,w and 
z as constants as in Chapter 2. The 3D B1 distribution determined by the actual flip-angle 
imaging (AFI) method (TR1/TR2=30/130ms, FA=45°), was taken as a standard for FA 
corrections. Because slice-profile errors are not accounted for in 3D AFI mapping, only 
the middle slices of slab-selective SE and PS MRI acquisitions were used for validation 
studies. 
Coil receiver sensitivity maps were also computed based on the signal intensities 
of GRE images acquired from agarose phantoms (TR/TE=2 or 3s/3ms), and corrected for 
FA, T1 and T2. These were fitted to a 2D quadratic polynomial and used to normalize the 
calculated PD images, for the purpose of generating PD images in percent units (pu) 
relative to water[74]. The standard PD images were corrected for the FA, T1 and T2 using 
the applicable TR/TE values, as applied to the longest TR PS sequence. The ‘Dual-τ 
Dual-FA’ PD images were corrected with the ‘Dual-τ Dual-FA’ FA, T1 and T2 values.  
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Phantom ‘Dual-τ Dual-FA’ T1 and T2 values were compared with PS and SE 
measurements as percentage differences from the standard values. The means ±SD were 
determined for each phantom compartment, and for brain regions-of-interest. In phantom 
‘Dual-τ Dual-FA’ MRI experiments, S1 was acquired with a 15° GRE selective 
excitation, and S2 and S3 were excited by 0º BIR-4 pulses followed by 60º slab-selective 
3D GRE sequences, with τ3=2τ2=20ms (TR/TE=609/3.5ms; total scan time=10.1min; 
elliptical k-space sampling, PE=330 phase encodes; 80x80x14 reconstruction matrix; 
FOV= 70x130x130mm; BW=117kHz; resolution=5x2x2mm; the central 7th coronal slice 
was analyzed). The FOV and matrix parameters were modified for human studies (FOV= 
200x35x200mm, BW=180kHz; elliptically sampled k-space; PE=619; 224x224x7 
reconstruction matrix; resolution=1x5x1mm; total scan time=18.9min, 4th axial slice 
analyzed). 
3.2.3 Results 
The Monte Carlo simulations show that T1 was unaffected by the pre-pulse length 
τ2. However, increasing TR above T1 did introduce a small (systematic) error in the mean 
T1 compared to the true value. With the shortest (scanner-limited) TR of 609ms and 
T2=80ms, the mean systematic error (±SD) in T1 was 0.6%±11% for T1=1 s (Fig. 3.1a). 
As a percentage, the SD in T1 decreased monotonically from 30% to 9% as T1 increased 
from 0.3s to 1.5s. With TR=609ms, τ2=10ms and T1=1s, the mean error for T2=45ms is 
1%±18% (Fig. 3.1d).  
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Experimental ‘Dual-τ Dual-FA’ T1, T2, and PD images of the phantom are shown 
in Fig. 3.2. The images were segmented into compartments using a region-growth 
algorithm. Aside from regions with T2>150ms which are not accurately determined by 
the ‘Dual-τ Dual-FA’ method[69], the errors in T2 were 3.9% ±6.5% vs SE (Fig. 3.2f). 
The error in T1 for the four segmented regions was 11% ±6.5% vs PS (Fig. 3.2e). The PD 
measured in pu[74], has an SD of 9.5% in the phantom (Fig. 3.2a). 
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Fig 3.2 Color-coded ‘Dual-τ Dual-FA’ images of (a) PD, (b) T
1
, and (c) T
2
 in the three-
tube bottle gel phantom. Part (d) shows an AFI B
1 
map of the phantom. Part (e) plots the 
‘Dual-τ Dual-FA’ T
1
 vs. the standard PS T
1
 for each compartment. Part (f) plots the ‘Dual-
τ Dual-FA’ T
2
 vs. SE T
2
 in the compartments (above 150ms, the ‘Dual-τ Dual-FA’ T
2
 is 





maps are in ms, and the B
1
 map is % of the nominal FA. 
 
Fig. 3.3 depicts ‘Dual-τ Dual-FA’ brain MRI results. The ‘Dual-τ Dual-FA’ T1 
values sampled in the annotated regions were 1.65 ±0.12s for grey matter (GM) and 1.06 
±0.08s for white matter (WM). These are consistent with literature values of: 
1.33±0.001s[75], 1.47±.05s[76], and 1.82±0.11[77] for GM; and 0.83±0.01s[75], 
1.08±0.05s[77], 1.11±0.05s[76], and 1.11s[78] for WM. The ‘Dual-τ Dual-FA’ T2 values 
were 68±9ms for GM and 54±5ms for WM, compared to SE results of 73±5ms and 
54±5ms, respectively. Published T2 values for comparison are: 71±10ms[59], 




Fig 3.3 Color coded ‘Dual-τ Dual-FA’ (a) PD, (b) T
1
(b) and (c) T
2
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3.3 Dual-τ Dual-TR Method 
3.3.1 Theory 
Instead of varying FA to encode T1 as in the ‘Dual-τ Dual-FA’ method, the ‘Dual-
τ Dual-TR’ method varies TR along with τ in the following three acquisitions. (B1) A 
first signal, S1, is acquired in the steady-state at a short TR=TR1 using a short 0° adiabatic 
pre-pulse of duration τ1, followed by a GRE MRI sequence with an FA of φ. (B2) A 
second signal, S2, is acquired with a longer TR2=2*TR1 and the same τ1 0° adiabatic pre-
pulse followed by the φ pulse, GRE sequence. (B3) A third steady-state signal S3 is 
acquired also with TR=TR2, but using an adiabatic pre-pulse of duration τ2=2τ1, followed 
by the same φ pulse, GRE sequence. 
The three resulting signals are: 
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where Ep1 =Ep(τ1) and E1’=exp(-TR2/T1). Because τ2 = 2τ1, TR2=2TR1, we have Ep2=Ep1
2 
and E1’=E1
2. This equation set can be solved by the numerical iteration of: 
, , and , 
           [3.2] 
after setting initial values for E1 and Ep1. When φ=90º the solutions are analytic: 
, -1, and     [3.3] 
 In all our experiments the FA was set nominally to φ = 90º. However, the 
presence of B1 inhomogeneities generally requires that a FA (or B1) map must be 
acquired and the local FAs substituted into the iterative algorithm. Initial values for Ep1 
and E1 are calculated from Eq. [3.3]. We recorded final values after ten iterations of Eqs. 
[3.2], but convergence was usually achieved at 4 iterations. T1 and T2 values were 
calculated by substituting Ep1 for Ep2 and τ1 for τ2, and TR1 for TR in Eq. [2.7]. The value 
of TR1 is selected based on Monte Carlo error analysis of the Bloch equation as described 
below. 
3.3.2 Methods 
3.3.2.1 Numeric simulations 
Monte Carlo simulations of the ‘Dual-τ Dual-TR’ method used the same noise, T1 
and T2 ranges as in Sec. 3.2, but with FA=90° for all three GRE acquisitions. Because 
validation experiments for this method used the Philips system’s birdcage 
transmit/receive head-coil with a higher B1, we set B1=20µT, fmax=15kHz, and 
τ2=2τ1=20ms for the BIR-4 pulse. To determine a suitable TR1, the error in T1 was 



















































Ep1  S3 / S2  E1 S2 / S1  
M0 S1 / [(1E1)Ep1]
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3.3.2.2 MRI validations on phantoms 
Experiments were performed with the Philips’ head-coil and BIR-4 pulse parameters as 
simulated (Sec. 3.3.2.1). The same 4-compartment phantom used in ‘Dual-τ Dual-FA’ 
experiments (Sec. 3.2.2.2) was imaged. S1 and S2 were acquired with a τ1=10ms 0° BIR-4 
pre-pulse followed by a nominal-90° slab-selective excitation with TR=530ms and 
1060ms, respectively (FOV=70x130x130 mm; resolution=5x2x2mm; BW=117kHz; 
elliptically sampled k-space, PE=388; 80 x80x7 reconstruction matrix; total scan 
time=17.1min, central 4th coronal slice analyzed). For step B3, S3 was acquired with the 
same nominal-90° selective excitation, but TR was limited to 1060ms by scanner RF 
power constraints on the τ2=20ms 0° adiabatic pre-pulse. Measured ‘Dual-τ Dual-TR’ T1 
and T2 values were compared to standard SE and PS values acquired with the same 
experimental parameters used in the ‘Dual-τ Dual-FA’ experiments. Standard and ‘Dual-τ 
Dual-TR’ PD images were computed as in Sec. 3.2.2.2, except that the ‘Dual-τ Dual-TR’ 
PD images were corrected using the ‘Dual-τ Dual-TR’ T1 and T2 values. 
3.3.3 Results 
The Monte Carlo simulations of the ‘Dual-τ Dual-TR’ method showed that the 
SD of the estimated T1 decreased from 27% to 10% as TR1 increased from 0.3s to 1.2s 
(Fig. 3.4a), and that the choice of TR1 had little effect on the T2 measurement. We chose 
TR1=0.53s as a compromise between scan-time, T1 accuracy, and our scanner’s RF 
power constraints for τ1=10ms. With these settings, the T1 error of the ‘Dual-τ Dual-TR’ 
experiment varied from 0.6%±11% to 2%±22% for 0.3≤T1≤1.5s with T2=80ms. The T2 
error for tissue with (T1, T2)=(1s, 45ms) was 1.8±17% (Fig. 3.1b, e).  
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Fig 3.4 Monte Carlo simulations used for selecting TR and FA: (a) the SD in the ‘Dual-τ 
Dual-TR T
1
 experiment as a function of TR; and the SD in the ‘Four-FA’ T
1
 experiment 




, and (e) 
3
, with each of the other two FAs set to the most 
favorable values (30°, 80°, 140°, respectively), and SNR=50. The horizontal blue line is 
the true (input) T
1





, varied independently with a noise level=M0/100. The scale reflects 
the SD as a fraction of the true T
1
. (c) The normalized steady-state signal as a function 
of nominal FA for B
1
-field variations from 50-100% (q =0.5-1.0), TR=25ms and 
TR=600ms. B
1
 field differences can only be differentiated at long TR and high FA. 
 
Experimental ‘Dual-τ Dual-TR’ T1, T2 and PD maps of the 4-compartment 
phantom are depicted in Fig. 3.5, with the relaxation values plotted below. The mean 
errors are 6.6±11% for T1 in the range 0.65≤T1≤1.3s; and 2.7%±5.2% for T2 in the range 
29ms≤T2≤187ms. The SD of the PD signal is 8.8%. 
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Fig 3.5 In vitro color-coded ‘Dual-τ Dual-TR’ (a) PD, (b) T
1
 and (c) T
2
 from the same 




 values for the four 
compartments compared to measured standard PS and SE values (the black line is the 
identity line). 
 
3.4 Four-FA Method 
3.4.1 Theory 
The accuracy of all of the above methods, including the standards, depends on 
accurate knowledge of the FA. Fast FA mapping techniques such as AFI or as provided 
by the MRI scanner manufacturer, require at least two acquisitions and are generally 
limited in accuracy to the central uniform region of selectively excited slices or slabs[79]. 
Thus, when FAs are uncertain and an FA map is required, even the minimum-acquisition 
‘Dual-τ Dual-FA’ and ‘Dual-τ Dual-TR’ methods actually require at least five 
acquisitions to produce accurate T1, T2 and PD maps. This is greater than the minimum 
possible number of acquisitions–four, that could be used to measure the independent 
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parameters T1, T2, PD, and FA. The ‘Four-FA’ method achieves this by incorporating an 
FA (or B1) determination in the same protocol. 
 The ‘Four-FA’ method acquires three steady-state signals S1, S2 and S3 from 
spoiled GRE MRI sequences each applied with the same TR=TR1, but different nominal 
FAs, θ1, θ2, and θ3 in steps C1-C3. A fourth signal, S4, is acquired in step C4, using a long 
0º adiabatic pre-pulse of duration τ2 followed by a GRE sequence with FA=θ4, and 
TR=TR2. In these studies, we set the actual FAs equal to the nominal FAs scaled by a 
factor q that reflects the effect of a nonuniform B1-field at each (pixel) location. The four 
steady-state signals are thus: 
 ,  ,  and 
 .       [3.4] 
Here, the B1 scaling factor, q, proton density M0, and T1 attenuation factor E1 are 
solved by three-coefficient least-squares fitting of the signal curve with x=[θ1, θ2, θ3], 
y=[S1, S2, S3], coeff=[M0, E1, q], minimizing ||F(x,coeff)-y||2
2. T1 is obtained from E1. 
Then M0, q, and E1’ are substituted into the expression for S4 to obtain Ep2, from which 
T2 is obtained using Eq. [2.7]. Note that the value of T2 is determined by S4, after 
computing the other parameters from S1, S2, or S3 in Eq. [3.4]. Also, by choosing θ4=θ1, 
the θ1 and M0 terms in S4 and S1 cancel in Eq. [3.4], enabling a direct computation of T2 
from the ratio S4/S1, once T1 is known. 
 As noted earlier, short 0° adiabatic pre-pulses added to the three sequences in 
steps C1-C3 can control for the effects of the delay following the adiabatic pre-pulse used 
in step C4. The T2 attenuation from a 1ms pre-pulse, for example, is negligible (<3% for 
 
S1  M0
(1 E1)sin(q  1)
1 E1 cos(q 1)  
S2  M0
(1 E1)sin(q 2)
1 E1 cos(q 2 )  
S3  M0
(1 E1)sin(q 3)
1 E1 cos(q  3)
 
S4  M0
(1 E1 ')sin(q 4 )Ep2
1 E1 'cos(q 4 )Ep2
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T2>13ms and <0.7% for brain tissue), and does not significantly affect the solution of Eq. 
(10) as presented. The values of θ1, θ2, and θ3 are chosen as those that minimize T1 
quantification errors based on Monte Carlo simulations of the Bloch equations over an 
appropriate range of relaxation times. This results in at least one FA>90°. 
3.4.2 Slice profile correction 
The ‘Four-FA’ method can correct for an inhomogeneous B1 field, as long as the 
slice profiles excited by θ1, θ2 and θ3 have the same shape with magnitudes proportional 
to sin(q.θ). However, this does not hold for FA>90°[80] where signals from the edge of 
the profile can greatly exceed sin(q.θ) at the slice center (Fig. 3.6)[81]. For full or slab-
selective 3D MRI[82], the middle slice of an excited slab is typically unperturbed by the 
slice profile, and yields accurate results even with short, truncated slab-selective 
excitation pulses. However, for 2D MRI employing a single slice selection with  FA>90° 
pulses, the integrated effect of slice profile imperfections can be substantial. In this case, 
the T1 error can be calibrated by a factor generated by Bloch equation simulations and/or 
determined experimentally, as detailed below. 
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Fig 3.6(a) Waveforms of ‘spredrex’ (blue) and truncated ‘sinc’(grey) FA=80° pulses used 
in our ‘Four-FA’ MRI sequences. The ‘spredrex’ pulse is more than twice as long as the 
truncated sinc pulse. Parts (b-d) show the slice profiles for the spredrex and sinc pulses 
determined from the magnitude of the transverse magnetization for (b) 30°, (c) 80°, and 
(d) 140° pulses used in the ‘Four-FA’ studies. The dashed red line is an ideal 5mm slice 
pulse profile.  
 
 
3.4.3 Numerical simulations 
Monte Carlo simulations of the ‘Four-FA’ method used the same T1 range as the 
earlier simulations, but a larger T2 range of 0≤T2≤190ms, and a noise level of M0/100 or 
an SNR of 50. The same BIR-4 pulse as the ‘Dual-τ Dual-TR’ was used with τ = 
20ms[69]. FAs were successively incremented by 5° from 5°-180° to determine the 
values of θ1, θ2 and θ3 that minimized the error in T1. The rationale for setting the FAs is 
as follows. Fig. 3.4c shows that in order to differentiate B1, the signal curves should be 
sampled at FAs that span the range 0-180°, and that maximum differentiation occurring 
at the highest FA. If we allow a 25% variation in B1, the nominal FA cannot be greater 
than 140° lest the actual FA exceed 180°, which would cause aliasing. This sets the 
maximum FA for optimally differentiating B1 inhomogeneity at ~140°. The other two 
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FAs are basically chosen to minimize the error in T1, based on the Monte Carlo 
simulations. 
The effect of an imperfect slice profile is to alter the (q.θ) terms in Eq. [3.4] as a 
function of position across the slice (Fig. 3.6). This is not accounted by the global 
solution of Eq. [3.4]. In addition to a standard ‘sinc’ pulse excitation, the Philips’ scanner 
can provide ‘spredrex’ excitation pulses (Fig.3.6a), which have an improved slice profile 
at high FA across the center of the slice, as compared to a truncated ‘sinc’ pulse 
(Fig.3.6d) [81]. A Bloch equation simulation of the effect of slice profile imperfections 
on T1 was performed by digitizing ‘spredrex’ pulses into 996 rectangular segments, with 
the pulse length, amplitude, and gradient strength set according to the scanner’s pulse 
viewer tool and T2=50ms and 100ms. The simulated ‘Four-FA’ T1 was compared with 
the true (input) T1, and a linear correction curve computed. To account for possible 
system non-linearity in the scanner’s delivery of the RF waveform to the coil, the 
response assuming a small quadratic term included in the output response, was also 
computed. 
3.4.4 Experimental validation 
The ‘Four-FA’ method was validated with a phantom comprised of 11 isolated 
gel-filled tubes spanning a broader range of T1 and T2 than used for the earlier methods 
(186 ≤T1 ≤1332ms, 13.2 ≤T2 ≤227ms), and in IRB-approved studies of the human brain. 
A 1ms 0° adiabatic pre-pulse was added 9ms prior to slice-selective excitation in steps 
C1-C3, while step C4 used a 20ms BIR-4 pulse applied with the same pre-pulse delay. In 
phantom studies, S1-S4 were acquired using standard 2D and (slab-selective) 3D GRE 
MRI (TR1=600; TR2=1036ms; TE=1.9-3.0ms. 3D: FOV=25x160x160mm; resolution 
5x2x2mm; BW=144kHz; elliptically sampled k-space; PE=353; reconstruction matrix 
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80x80x5; total scan time=16.7min, 3rd coronal slice analyzed. 2D: FOV=200x5x200mm; 
resolution=1x5x1mm; BW=180kHz; PE=200; reconstruction matrix 224x224; total scan 
time=9.6min) with nominal FAs of θ1=30°, θ2=80°, θ3=140°, and θ4=30°.  
Human brain studies utilized the same sequences, except that the 3D array had 
same-sized sections as 2D (3D FOV=200x 25x200mm; elliptically sampled k-space;  
PE=550; reconstruction matrix 224x224x5; resolution 1x5x1mm; BW=180kHz; total 3D 
scan time=26min, 3rd axial slice analyzed).  
The in vitro ‘Four-FA’ relaxation measurements were compared to 3D SE T2 data 
acquired with 14 echoes (TR/TE=500/15ms), and PS T1 measurements acquired the same 
as in Sec. 3.2.2.2. The in vivo ‘Four-FA’ measurements were compared with PS T1 data 
acquired using a slab-selective 3D GRE sequence at TR=100, 600, 1200ms and FA=90°; 
and with standard 32-echo 3D SE T2 data acquired at TR=725ms. Standard and ‘Four-
FA’ PD images were computed as in Sec. 3.2.2.2, except that the ‘Four-FA’ PD images 
were corrected using the ‘Four-FA’ T1, T2 and FA values.  
The effect of non-uniform slice profiles on the observed T1 for the 2D (slice-
selective) ‘Four-FA’ method with the ‘spredrex’ pulse was measured in the 11-tube 
phantom, and the results compared to the numerical simulations with and without a small 
quadratic RF system response. The experimental results relating 2D ‘Four-FA’ T1 to 3D 
PS T1 were fitted to a linear regression line and used to correct 2D T1 values for slice 




3.4.5.1 Numerical simulations 
Bloch equation simulations of the ‘Four-FA’ method in Fig. 3.4c show that 
increasing TR increases the dispersion in steady-state signals elicited by different FAs, 
and improves the accuracy of T1 and B1 measurements. The Monte Carlo simulations 
show that the error in T1 decreases monotonically with increasing θ3 up to 180° (Fig. 
3.4e). Setting θ3 = 140° to accommodate a ~25% B1 variation, the error in T1 increases 
monotonically with θ1, and has a minimum for θ2~80°. A plot of the SD in T1 wherein θ1 
and θ2 are varied independently, confirmed that noise is minimal with a θ1 of 20°-30° and 
a θ2 of 70°-100° (Fig. 3.4f). Accordingly, we chose θ1=30°and θ2=80°.  
Monte Carlo simulations performed with θ4=θ1 (to cancel the θ1 and M0 terms in 
Eq. [3.4] show that the uncertainty or SD in T2 is <3% for 20°≤ θ4≤40°, and does not vary 
by more than 2% for choices of TR2 in the range 0.3≤TR2≤1s. Therefore, we chose the 
shortest TR allowed by the scanner for step C4: TR2 =1.032s. With TR1=0.6s, and 
T2=80ms, the simulations show that the uncertainty in T1 measured by the ‘Four-FA’ 
experiment decreases from 4±19% to 1.6±7.5% as T1 increases from 0.3 to 1.5s (Fig. 
3.1c). With T1=1s, TR2=1.032s, τ=20ms, the error in T2 is ≤ 0.4±27%, increasing with T2 
≤190ms (Fig. 3.1f). 
 65 
 
Fig 3.7 Effect of slice profile on T
1




, for a linear system response 












. (b) Effect of the linear and 
second-order responses on the ‘Spredrex’ excitation waveform for a maximum B
1
=20µT 
(FA=140°). (c) Bloch equation simulation of the ‘Four-FA’ T
1
 acquired with the 2D 
‘Spredrex’ excitation pulse from (b), compared to the true T
1
 assuming linear (red stars) 
and non-linear (green crosses) RF system responses. Blue circles show the 



















Results from the slice profile simulations comparing the apparent T1 with the true 
T1 for the ‘spredrex’ excitation used in the slice-selective (2D) ‘Four-FA’ experiment are 
plotted in Fig. 3.7. The star symbols (red) assume a linear RF field response. The crosses 
(green) show the effect of assuming a mild quadratic nonlinearity in the delivered RF 
field (Fig. 3.7a), which barely attenuates the pulses’ side-lobes (Fig. 3.7b). The integrated 
effect of the slice profile excitation was to reduce the observed T1 compared to the true 
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T1: by about 20% and 28% at T1=1s, for the linear and non-linear profiles, respectively 
(Fig. 3.7c). These results did not change appreciably with T2. 
3.4.5.2. Experiments 
Fig. 3.8 compares 3D slab-selective ‘Four-FA’ T1, T2 and B1 maps with the 
standard images acquired from the 11-tube phantom. Mean ‘Four-FA’ values are plotted 
against standard values in the first column. Mean differences are all within 5%: the error 
in T1 is 2.5%±14% and the error in FA or B1 is 0.9%±8%. Even though the tube in the 
bottom left of Fig.3.8c has an anomalously poor B0 at its rim which compromises the 
performance of the adiabatic pulse used for the T2 determination, the error in T2 is just 
3.6%±9%. The SD of the sensitivity- and T2-corrected PD image of the phantom was 
±5.3% (not shown). 
Fig. 3.9 shows 3D ‘Four-FA’ results from two volunteers. T1 and T2 values in the 
blue boxes in the WM region and the green boxes in the GM region are compared with 
standard T1 and T2 values from the same region. The mean ±SD error in T1 is -4.0±8.5% 
and -5.5±6.0% for volunteers A and B respectively. The T2 errors are 0.9±7.4% and 
1.2±10.1%, respectively. For WM, the mean relaxation values are (T1, T2)=(859, 64.9) 
for volunteer A, and (865, 64.7) for volunteer B in ms. For GM, (T1, T2)=(1387, 75.4) 
and (1351, 77.0) in ms. These are consistent with prior published values listed in Sec. 
3.2.3. On the other hand, contrast between cerebral spinal fluid (CSF) and neural tissue is 
poor in the standard PS T1 and SE T2 maps where the TRs (of 1.2s and 0.6s) are much 
less than T1 and T2 of CSF (in the range of 4/2s)[68]. Indeed, all of the T1 and T2 
measurements of CSF appear lower than literature values, although the ‘Four-FA’ images 
provide much higher contrast between CSF and WM. 
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A comparison of the 2D slice-selective ‘Four-FA’ T1 measurements with the 
standard 3D PS T1 measurements taken as the ‘True T1’, is included in Fig. 3.7(c). The 
empirical data (blue points and line; R2=0.995) are consistent with the simulation (green) 
that assumes a small (0.004 B1
2) quadratic RF response. Fig.3.10 compares 2D ‘Four-FA’ 
brain T1 and T2 maps computed without and with the empirical slice profile correction, 
with corresponding 3D PS T1 and 3D SE T2 results which are not subject to slice profile 
effects. As expected, the correction primarily affects T1, reducing the 2D ‘Four-FA’ 
errors in the boxes that were annotated in Fig. 3.9 from -33±5% to -3.6±6% for T1, and 
from -9.7±3.8% to -8.5±3.6% for T2. 
 
Fig 3.8 ‘Four-FA’ results vs. reference values (column 1), and corresponding ‘Four-FA’ 
(column 2) and reference images (column 3) from the 11-tube phantom. Color scales are 
the same for each row (row a, B
1
 distribution, % nominal FA; row b, T
1






Fig 3.9 In vivo 3D ‘Four-FA’ images for two healthy volunteers (A, column a; B, column 
c) compared with corresponding standard maps from the same subjects (columns b and 





scales are in ms, the B
1
 scale is in % and PD is in pu. ‘Four-FA’ relaxation values in the 
annotated boxes are compared with PS T
1
 and SE T
2
 values in the text. The poorer SNR 




 maps is attributable to the TR settings used 




Fig 3.10 Fig. 2D ‘Four-FA’ T
1
 (Row a) and T
2
 (Row b) before and after application of 
slice profile corrections, as compared to standard PS and SE measurements from the 
central slice of 3D data sets, which do not have the slice profile problem. GM and WM 
show good agreement with the standards. The data are from Volunteer A in Fig. 3.9, and 
the scales are in ms.  
 
3.5. Efficiency and accuracy  
3.5.1 Theory 
The theoretical efficiency of a T1 method, T1, has been defined as T1 divided by 
the SD in T1, per square-root of the scan time, T1, for a unit random noise with SD=0 in 
the underlying signal[60, 83, 84]. By extension, the efficiencies in determining the mean 
values of T1, T2, B1 and PD (or M0) are: 
 and   [3.5] 
where the ’s are SDs in the respective measurements, and Ts is the total scan time for 
acquiring T1, T2, B1 and M0 in the combined experiment. Note that while the ’s reflect 
the scatter in the measured parameters, they do not show the accuracy of the 
determinations. We therefore compute the fractional accuracy or systematic error, defined 














input values, divided by the true value. Because accuracy is arguably as important as 
efficiency, we divide  by the accuracy, /(mean error), to create a figure-of-merit 
reflecting the efficiency per unit accuracy. 
3.5.2 Methods 
The efficiency and accuracy of the ‘Four-FA’ method were determined by Monte 
Carlo simulations for true values of (T1, T2) = (860, 65ms) and (1360, 75ms) to 
approximate WM and GM relaxation, respectively, as measured in PS, SE and ‘Four-FA’ 
experiments. Simulations were also performed with (T1, T2) = (1000, 70ms), which falls 
in the middle of this range. 104 runs were performed with four levels of noise (0=M0/50, 
M0/100, M0/150 and M0/200) added to the theoretical signal strengths. For comparison, 
the efficiency and accuracy were also simulated for the following common and efficient 
T1, T2, and PD imaging methods: (i) standard PS (TR=0.1, 0.6, and 1.2s) combined with 
a multi-SE sequence (TR=0.5s; 14 echoes); (ii) DESPOT1/2[60] (TR=3.4ms, NEX=5; 
DESPOT1 FA=3°, 12°; DESPOT2 FA=20°, 80°); (iii) and IR TrueFISP[61] (with 
TR=6.46ms, NEX=5, FA=45°, 5s delay ever 21 PE steps, 38 images acquired). The 
efficiencies were calculated from Eqs. [3.5] with the duration of a standard AFI sequence 
(FA=45°, TR1/2=30/130ms) added to all methods lacking a B1-mapping feature, in order 
to provide an equivalent comparison to the ‘Four-FA’ method. Efficiencies were also 
computed without the AFI sequence for reference. The T1 and T2 efficiency of the MRF 
method without AFI were determined from results presented in Ref. [68] that show it to 
have ~2.1 and ~1.6 times the T1 and T2 efficiencies as DESPOT1 and DEPOT2, 
respectively, at T1/T2 values of 985/67ms. The efficiency of MRF with AFI, assumed a 
200x200 AFI image matrix[68]. 
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3.5.3 Results 
With 0=M0/100 and input (T1, T2)=(1000, 70ms), the Monte Carlo simulation of 
the ‘Four-FA’ method yielded a mean T1 of 1007±114(SD) ms, that is, a mean error of 
7ms or 0.7%. The scan time for one phase-encoded acquisition was 
3TR1+TR2=0.6x3+1.036=2.836 s. Thus, the T1 efficiency of the Four-FA method was 
1000/(114√2.836)=5.2, and its efficiency/error was 5.2/0.7=7.4. The efficiency and mean 
error for all the methods being compared are listed in Table 3.2. Except for the MRF 
method for which information is presently incomplete, DESPOT1/2 is the most efficient 
for T1 T2 mapping when no B1 mapping is included, as was previously reported[60]. 
However, adding AFI to provide B1-calibration reduces the T1 and T2 efficiency of 
DESPOT1/2 as compared to ‘Four-FA’, while DESPOT1/2 was 6-times less accurate. 
The ‘Four-FA’ method was at least twice as efficient as AFI in B1 mapping, and more 
than 50 times more accurate. The ‘Four-FA’ method outperformed in efficiency per unit 
accuracy for jointly measuring T1, T2, B1 (or FA), and PD, with the exception that PD 
measured with IR True-FISP had zero mean error. The efficiency and mean errors varied 
with T1, T2 and 0, and typically improved with decreasing noise, 0<M0/100. Analysis 
of the ‘Dual-τ Dual-TR’ and ‘Dual-τ Dual-FA’ methods showed they were less efficient 
than the ‘Four-FA’ method. 
3.6 Discussion 
This paper extends the application of the T2 filtering property of 0° adiabatic pre-
pulses to combined T1, T2 and PD imaging methods, by introducing three new imaging 







Table 3.2 T1, T2, B1 and M0 efficiency, mean error (%), and [efficiency/mean error] for 
‘Four-FA’ and relative quantitative mapping methods at T1=1s, T2=70ms and noise level 






with(w/o) AFI  
DESPOT1/2  
with(w/o) AFI  
IR TrueFISP  
with(w/o) AFI  
MRF*  
with(w/o) AFI  
T
1
 efficiency  5.2  3.6 (3.7)  4.5 (8.2) a  2.0 (2.1)  8.4 (16)  
mean error(%)  0.7  2.3  9.3  17  -  
efficiency/error  7.4  1.6 (1.6)  0.5 (0.9)  0.1 (0.1)   
T
2
 efficiency  4.7  7.2 (7.4)  4.3 (7.9) a 2.7 (2.8)  6.3 (12)  
mean error(%)  1.4  4.5  9.5 b  8.7  -  
efficiency/error  3.4  1.6 (1.6)  0.5 (0.8)  0.3 (0.3)   
B
1
 efficiency  23  2.8  9  2.8  9.5  
mean error(%)  0.06  3.2  3.2  3.2  3.2  
efficiency/error  383  0.9  2.8  0.9  3  
M
0
 efficiency  11.8  8.0 (8.3)  9 (17)  53(55)  -  
mean error(%)  0.2  0.2 c 3.6  0.03  -  
efficiency/error  59  40 (42) c 2.5 (4.7)  1800 (1800)   
Notes: The relative standings of the methods vary with T1 & T2 as follows. aDESPOT1/2 
has (<10%) higher efficiency than ‘Four-FA’ at (T1, T2)= (860ms, 65ms). bThe error in 
DESPOT1/2<TrueFISP error at (T1, T2)=(860ms, 65ms). cThe error and efficiency/error 
in the standard method are respectively lower and higher than ‘Four-FA’ at (T1, 
T2)=(1360ms, 75ms). 
*Efficiency was estimated from Fig. 5 of [85] at T1=985ms and T2=67ms (% error 
estimates from the figure, and M0 efficiency data were unavailable). 
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the ‘Dual-τ Dual-TR’ and ‘Four-FA’ methods were not previously described, we note 
that the ‘Dual-τ Dual-FA’ method, was previously introduced as the ‘Tri-τ’ method for T1 
and T2 measurements, but not for MRI[69] (name corrected to ‘Dual-τ Dual-FA’ in 
Chapter 2). In fact, inaccuracies in both T1 and T2 due to what turned out to be B0, B1 and 
slice profile effects when attempting MRI with the ‘Tri-τ’ method are what inspired the 
present work.  
For a combined T1 and T2 MRI experiment, the use of 0° adiabatic pre-pulses 
have advantages over spin-echoes in avoiding the confounding effects of saturation that 
arise when the excitation pulses are non-90° or non-uniform[72, 86]. T2 accuracy is 
enhanced by including a short 0° adiabatic pre-pulse in at least one sequence, as a 
control. While SSFP sequences also generate stimulated echoes and provide sensitivity to 
all three of T2, T1 and M0[87], the peak of the true T2 echo signal actually falls at the 
center of the next excitation pulse[88]. Moving the echo to the center of the acquisition 
window by means of MRI gradients–as is invariably done in MRI–renders the signal 
prone to the effects of T2*, motion during the MRI gradients, as well as the usual B1 
inhomogeneity and off-resonance effects. 
Indeed, all existing T1 methods are prone to errors in B1 when deployed with 
sequence TRs ≤T1 and large FAs. We chose incoherent steady-state sequences for T1 
encoding, because unlike transient methods (Table 3.1) they are amenable to the repeat 
acquisitions required for spatial encoding, which can allow greater versatility in adjusting 
the number of averages or spatial encoding steps than approaches that sample the 
transient recovery of the magnetization. The primary determinant of accuracy was B1 
inhomogeneity which is intrinsically worse at 3T compared to lower fields, owing to RF 
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penetration effects. When incorporated into 3D or slab-selective sequences with FA 
corrections provided by our scanner’s B1 mapping sequence, all of the new methods 
agreed experimentally with the standard 3D SE and PS methods within 11%. However, in 
2D slice-selective sequences, even though the ‘Four-FA’ method yielded results 
comparable to standard 2D slice-selective SE and PS measurements, the T1 
measurements–including those acquired with standard 2D PS–all differed significantly 
from the 3D measures. This is attributable to the inadequacy of the scanner’s AFI method 
for addressing slice profile effects[79]. Even so, adding a 2D AFI correction to the 2D 
measurements did not fully correct for the T1 differences between any of the 2D images 
and the 3D PS results acquired for reference. This means that the FA measured by the 
scanner’s standard AFI protocol was insufficient to permit accurate correction of T1 
measured by 2D MRI. 
Since FA is so critical to accuracy, and B1-inhomogeneity is more problematic at 
≥3T fields, it makes most sense to formally integrate the FA or B1 correction, into the 
whole T1, T2 and PD imaging method, as exemplified by the ‘Four-FA’ method. This also 
ensures that the correct FA information specific to the actual T1 or T2 sequence(s) is 
acquired, which is typically not the case when standard AFI sequences are run. 
Combining the FA meaurement with the addition of only one acquisition via the ‘Four-
FA’ method, improves the overall efficiency as compared to adding the at-least-two 
acquisitions required for AFI, to an existing method.  
In fact, when B1 corrections derived from the scanner’s AFI protocol were used, 
both in vivo and in vitro studies yielded ‘Dual-τ Dual-FA’ T1 maps that were 
systematically slightly higher than the PS T1 maps (Fig. 3.5). Because results from a 
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conventional (non-MRI) ‘Dual-τ Dual-FA’ T1 NMR experiment previously demonstrated 
essential agreement with standard methods [69], we attributed the difference to the 
inadequacy of the scanner’s AFI B1 mapping protocol in replicating the FA distribution 
that was in effect during the ‘Dual-τ Dual-FA’ experiment. This was confirmed by 
phantom 2D ‘Four-FA’ validation experiments which revealed AFI B1 values that were 
~12% lower than the ‘Four-FA’ B1, and by numerical simulations of the effects of such 
B1 errors on T1. Indeed, when the effective B1 was measured using fully-relaxed 
experiments in which the FA was varied and the NMR signal fit to a sine curve, the 
‘Four-FA’ B1 was observed to agree with the measured B1 to within 0.4%. Clearly, 
greater accuracy in B1 mapping would at least improve the accuracy of ‘Dual-τ Dual-FA’ 
measurements, and likely T1 measured by other methods as well. In this regard, note that 
the SNR of ‘Four-FA’ B1 is more than twice that of the scanner’s AFI B1 map (Fig. 3.9).  
Because the ‘Dual-τ Dual-TR’ method uses the same FA ~90°, it is relatively 
insensitive to B1 mapping errors. The in vitro validation indicated accurate T1 and T2 
mapping over a wide range of T1 and T2. However the scanner’s built-in RF power 
constraints limited the shortest TR to ≥530ms for the Philips transmit/receive head coil, 
whereupon doubling the TR in steps B2 and B3 resulted in a total acquisition time that 
was comparable to a conventional T1 measurement. Consequently, we did not validate the 
‘Dual-τ Dual-TR’ method in vivo. The RF power associated with long adiabatic pulses is 
a significant limitation on long-τ acquisitions due to regulatory compliance[50]. It does 
not help that scanner power limits can over-state the deposited power by 2.2-fold or 
so[89]. 
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The ‘Four-FA’ method self-corrects for FA inhomogeneity. While it has been 
suggested that varying FA to estimate B1, M0 and T1 is an ill-posed problem[90], we have 
demonstrated that the three parameters can be fairly accurately estimated from a least 
possible number of acquisitions (Fig. 3.4c). Generally, TR should be chosen generally in 
a range ~T1/2, but the simulations and experiments show that a fixed TR of 600ms yields 
accurate results for TR/3≤T1≤ 2.5TR (Fig. 3.1c, Fig. 3.8b). With θ3>90°, the slice profile 
of the S3 acquisition of the ‘Four-FA’ method develops serious horns (Fig. 3.6d) which 
requires an additional correction for 2D MRI applications (Fig. 3.7c). A similar 
correction for FLASH T1 imaging was previously reported[91], and other slice-selective 
T1 imaging methods are likely to require FA- and/or TR-dependent slice-profile 
corrections beyond those provided by conventional B1 or AFI mapping to achieve 
accurate results. The need for such correction would be signified by the presence of 
differences between T1s measured in 2D and 3D images of the same subject or phantom. 
This, along with the fact that the image resolution along the slice selection direction 
usually can’t match that achievable with 3D MRI, however, may be considered minor 
disadvantages of 2D T1 MRI compared to the speed-up realized by reducing the number 
of phase encodes vs. 3D.  
Despite having the minimum theoretical number of steady-state acquisitions 
possible, the ‘Four-FA’ method nevertheless exhibited only average efficiency as defined 
by the conventional ‘’ metrics, in Monte Carlo simulations (Table 3.2). Its efficiency 
was poorer than both multi-SE (with 14 echoes) and MRF. However, the overall accuracy 
of the ‘Four-FA’ method was much better than SSFP based measurements and SE, which 
is not accounted for in the  metrics. The efficiency per unit accuracy, /(mean error), of 
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the ‘Four-FA’ method was generally many times higher than the other methods, with the 
caveat that we presently do not know whether the newest MRF approach[68] 
accommodates T2*, B1 and slice profile effects in its library of solutions.  
The primary reason for the longer acquisition times for all of the new methods 
proposed here, and for the ‘Four-FA’ method’s lower s compared to SSFP-based 
measurements (DESPOT1/2, IR TrueFISP, MRF), is their longer TRs. Here at 3T, the 
TRs were limited by RF power constraints on the long adiabatic pulses. A simple fix to 
this problem could be switching to a lower field. At 1.5T, for example, the SAR would be 
reduced to 25% or more, depending on how the scanner treats the regulatory limits on 
peak power. In this case, the TR in ‘Dual-τ Dual-FA’ and ‘Dual-TR Dual-FA’ could be 
reduced four-fold, reducing the total scan time to less than 5 mins for 7 slices in Figs 3.2, 
3.3, 3.5, for example. For the ‘Four-FA’ method, SAR only affects the final acquisition 
with the long BIR-4 pulse, which again would be reduced four-fold at 1.5T. The ‘Four-
FA’ method is in addition affected by the need for a long TR to ensure accurate B1 
measurements. As discussed, accurate knowledge of B1 is critical to the credibility of all 
T1 methods (PS, IR, DESPOT1, IR-TrueFISP). If B1 is known, reducing TR from 600ms 
down to ~10ms for the ‘Four-FA’ method for example, not only reduces the scan time, 
but also results in a 11−22% higher T1 efficiency (without the last acquisition) than 
DESPOT1 without AFI, while still maintaining its advantage of a much smaller mean 
error of <2%. Indeed, the much higher accuracy seen with the ‘Four-FA’ method (Table 
3.2) is in good part due to the longer TR required for a much more accurate B1 
determination. 
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Implicit in the development of any minimum-acquisition T1 and T2 MRI protocols 
is the assumption that the number of relaxation components is limited. Here we have 
assumed that both are mono-exponential. Indeed, single-valued T1s and T2s are 
commonly reported for human studies, and often represent the only data available from 
MRI studies at a given B0. This is not to say that multiple components do not exist. Also, 
multi-component relaxation may not be distinguishable from mono-component relaxation 
combined with tissue heterogeneity, for example, due to mixtures of GM, WM and CSF 
present in brain pixels. However, in our PS and SE experiments acquired at multiple time 
points during relaxation, we found no evidence of multi-exponential decays that could 
not as easily be characterized by a single exponential. Moreover, the ‘Four-FA’ method 
measures T1 and T2 intrinsically differently from the PS and SE methods–and at different 
time scales. If T1 or T2 relaxation were multi-component, agreement would have been be 
problematic. 
In conclusion, the validation studies show results consistent with mapping using 
standard methods, and with prior published relaxation values for brain WM and GM 
tissue at 3T. The three methods described offer a minimum-acquisition option for 
imaging single-component T1, T2, and PD, potentially offering considerably higher 
efficiency per unit accuracy in the context of existing approaches, when B1-
inhomogeneity and slice profile affects are appropriately addressed. 
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Lipid-bearing intravascular atherosclerotic plaques have a high risk of rupture 
which can clog arteries and cause stroke or myocardial infarction. Such events are 
responsible for 25% of all mortality worldwide [92, 93]. The plaques evolve from early-
stage lesions, and their progression to those vulnerable to rupture may take decades. 
Differentiation of the lesions’ stage is crucial to determine its progression and response to 
interventions. The American Heart Association (AHA) has classified atherosclerotic 
lesions into Types I-VI, according to their histological composition and structure[94]. 
Type IV – VI lesions are considered to be advanced and have a significant risk of 
developing complications.  
There has been much research into the assessment of vessel wall characteristics 
using MRI, with the goal of detecting and classifying atherosclerotic lesions. 
Angiography visualizes the lumens of blood vessels, but the impact on vessel wall 
imaging has been limited. Recent studies show that the vessel wall and the presence of 
atherosclerosis are identifiable on T1- and T2-weighted black blood MRI (BBMRI) in the 
middle cerebral and intracranial arteries in the brains, with a resolution of ≥ 0.375 mm 
[95-97], but with suboptimal SNR. Ye et al. developed a 3D variable FA turbo SE (TSE) 
sequence, namely, “VISTA”, with an isotropic resolution of 0.5 mm, that improved SNR 
by 58% compared to BBMRI with the identical voxel volume [98]. Because the average 
common carotid artery wall thickness is ≤ 0.75 mm[99], the vessel wall occupies only 
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one pixel at this resolution. This leads to inaccurate quantification due to extensive partial 
volume effects (PVE). 
On the other hand, T1, T2 and PD are known to reflect the intrinsic characteristics 
of biological tissues and are responsible for the contrast in T1- and T2-weighted MRIs. 
The absolute values of T1, T2 and PD, as opposed to the image intensities in weighted 
images, are interpretable and provide quantitative measures that could potentially be used 
for diagnosis, with negligible influence from instrumental factors associated with 
different scanners [100]. Several studies have reported the relaxation times from 
atherosclerotic tissues [85, 101-105]. However, currently, all MRI approaches to 
diagnose vessel disease relies upon weighted images [106, 107]. This is because: (i) the 
standard multi-parametric mapping sequences require long scan times; (ii) the limited 
SNR and resolution introduce quantification errors in small vessel walls; and (iii) no 
feasible MRI  multi-parametric criteria for vessel disease classification have yet been 
developed. 
SNR can be dramatically improved with the use of an intravascular (IV) coil [108, 
109]. Recently, our group developed biocompatible IV coils [110, 111] that produce 
superior local SNR and ≤ 80 μm resolution at 3T. The IV coils receive signal within a 
radius of < 20mm. Thus, the scan time can be greatly reduced by encoding a much 
smaller FOV compared to receiving with conventional external coils. The IV coils can be 
placed at close proximity to the vessel wall, yielding a high local SNR that is sufficient 
for high-resolution, fast, quantitative vessel wall mapping.  
We posit that the measurement of all three T1, T2, and PD parameters, in 
conjunction with high resolution fast IV MRI, can be used for comprehensive 3D 
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classification of atherosclerotic disease. The hope is that this would provide quantitative 
criteria for disease characterization. Machine-learning [112] techniques have been 
developed and widely applied in high-dimensional classification. Supervised learning 
classifiers study training datasets and produce a function that can best categorize the data 
with minimum errors. The support vector machine (SVM) [113, 114] is a robust 
supervised learning algorithm that classifies the data using optimum decision boundaries 
in the high-dimensional feature space. 
In this chapter, high-resolution, IV MRI multi-parametric mapping is reported for 
the first time. The parametric maps of autopsied specimens were acquired using two fast 
mapping methods: 1) the “Four-FA” method, with minimum theoretical steady-state 
acquisitions and the highest accuracy [115]; and 2) the “MIX-TSE” method that yields 
maps for T1 and T2, which span almost the full biologic range with just a single scan 
[116, 117]. An SVM classifier was then trained using the multi-parametric maps to 
automatically differentiate the vessel disease stage. The results produced by the SVM 
classifier were compared to histology as the standard. 
4.2 Methods 
Human iliac or coronary artery segments that were harvested from decedents were 
acquired from the Pathology Department of the Johns Hopkins Hospital and from the 
NICHD Brain and Tissue Bank for Developmental Disorders (Baltimore, MD). This 
study was approved by the Johns Hopkins IRB. Ten vessel specimens were obtained from 
eight patients, five of which had diagnostic information available (Table 4.1). Although 
all patients were diagnosed with cardiovascular disease, atherosclerotic lesions were 
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observed at gross examination in five specimens. Specimens measured approximately 2-5 
cm long, with a diameter of 0.5-2.2 cm. 
 
 
Table 4.1 Patient information 
Age Sex Race Cause of 
Death 
64 male Caucasian Pulmonary 
hemorrhage 
61 female - CVD 
45 male Caucasian ASCVD 
58 male Caucasian ASCVD 
73 male Caucasian MI 
(CVD: cardiovascular disease, ASCVD: atherosclerotic cardiovascular disease, 





IVMRI was performed on a Philips 3T Achieva clinical MRI scanner (Philips 
Healthcare, Cleveland OH) using an in-house-built loopless IV coil. The coil consists a 
2.2mm outer diameter, 400mm-long semi-rigid copper coaxial cable antenna (UT-85-C, 
Micro-coax Inc., Pottstown PA), and a 39mm distal whip. The IV antenna was inserted 
into the lumen of the vessel segment, with the specimen centered at the cable-whip 
junction, where the sensitivity is the highest. The specimen and the antenna were 
positioned at the center of a phantom filled with 3.5g L-1 saline to mimic the body’s RF 
electrical properties at the MRI frequency (128 Hz).  
The IV antenna was used to receive RF signals after the body coil excitation. The 
Four-FA method acquired S1-4 (as in Section 3.4) with a TR=636 or 651ms; FA θ1-4 =30°, 
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80°, 140°, 30°; 3D voxel size =0.2x0.2x1.6mm3 or 0.27x0.27x5mm3; and 0° BIR4 
prepulse length τ=10ms in S4. 2D MIX-TSE was acquired with TRSE=1000, TRIR=1760, 
TE1/2=28.6ms/100ms, TI=0.5s, and 3D voxel size = 0.2x0.2x2mm
3. The Dixon method 
[118] was used to image separate water and fat components (TR=0.2s; TE=4.6, 5.8, 
6.9ms; FA=55°; 0.27x0.27x3mm3 voxels). 
Image analysis 
The IVMRI intensity was corrected by a 1/r inverse scaling map, with r being the 
distance from the center of the antenna; or by a 2D interpolated map of the signal from 
saline. The Four-FA multi-parametric maps were computed using S1-4 according to the 
formula in Section 3.4.1 [119]. The scanner’s built-in function was used to produce the 
MIX-TSE multi-parametric maps. 
Histology staining 
Transverse sections of the specimens were stained using hematoxylin and eosin 
(H&E, highlights calcification, lipid core and intraplaque hemorrhage) [120], Von Kossa 
(highlights mineralization), Verhoeff-Van Gieson (VVG, highlights elastic fibers) or 
Movat (highlights various constituents of cardiovascular tissue) methods to visualize the 
tissue structures. 
SVM classification  
The training and validation of the SVM classifier were performed using an object 
oriented scripting language Python (version 2.7.6, Spyder 2.2.5 IDE). The tissue 
components of the specimens were categorized into three classes according to histology: 
smooth muscle cells (SMC), early disease and advanced disease. 202 data points were 
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randomly sampled on the vessel walls in the regions with sufficient SNR and no shield 
current artifacts. The histology was determined using the methods as follows: early-stage 
lesions were stained green/blue on Movat, brown in Von Kossa and purple in VVG; 
advanced lesions were identified as black on Movat and VVG; SMC were stained light 
pink on H&E. The samples were labeled with the histology readings and the T1, T2, and 
PD values on the multi-parametric maps. The SVM was trained using the samples and 
tested using the “leave-one-out” [121] cross-validation method.  
The three-class SVM classifier generated probabilities for each sample belonging 
to each class. The class exhibiting the highest probability was determined to be the output 
class. In addition, a receiver operating characteristic (ROC) [122] analysis was performed 
to depict the sensitivity and specificity. For this, the samples were regrouped into disease 
and healthy tissue classes and used to train a two-class SVM classifier. Adjusting the 
discrimination threshold from 0-1 on the output disease probability generated the ROC 
curve.  
To compare with classification based on a single contrast, the three-class and two-
class SVMs were re-trained and re-tested using only T1, T2 or PD as the sample feature.  
4.4 Results 
An example of IV MRI on one specimen with 200 μm resolution is shown in Fig 
4.1a. The vessel wall structure including the plaque is clearly seen. In the Dixon lipid-
only image, fat is identifiable as the hyperintense signal in the periphery of the vessel 
wall (Fig 4.1b). Movat and Van Kossa staining confirmed the presence of early-stage 
thickened fibrosis tissue (Fig 4.1c). The Four-FA T1, T2, and PD maps with the same 
resolution show adequate SNR within R<10mm (Fig 4.1d-f). The T1 and T2 of saline are 
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beyond the validation range of Four-FA (see Section 3.4.5); thus, saline is masked out in 
the multi-parametric maps for clarity.  
 
Fig 4.1 a) GRE IV vessel wall image; b) Dixon lipid image; c) Movat and Van Kossa 
histology results of the vessel section; d-e) color-coded Four-FA quantitative parameter 
maps: d) T1 (ms), e) T2 (ms), f) PD(pu, percent units relative to water). 
 
The measured T1, T2, and PD values of the randomly sampled points were color-
labeled according to their tissue classes and plotted in 3D space, with each axis 
representing one parameter (Fig 4.2). The T1, T2, and PD values of the three classes are 
summarized in Table 4.2. They are consistent with the published values measured at 3T: 
54±13ms[85], 76±9ms[104], 69.1±6.6ms[105], and 39±5ms[103] for normal vessel wall 
T2; 685.9±166ms[105] and 844±96ms[103] for normal vessel wall T1; and 37±5ms[85], 










Fig 4.2 3D plot of T1, T2, and PD values of sampled points from three tissue classes: 
SMC(blue); early disease (red); and advanced disease (green). 
  
 









792±145 558±111 390±100 
T2 
(ms) 
62±23 44±16 34±16 
PD 
(ms) 
0.63±0.11 0.62±0.15 0.38±0.17 
 
 
The “leave-one-out” cross-validation results of the three-class SVM are 
summarized in Table 4.3, showing that the three-class SVM correctly classified 89-93% 
of SMC and advanced lesions. Test results exemplifying automatic tissue classification in 
a vessel are shown on a T1-weighted MRI in Fig. 4.3a. Compared to the VVG-stained 
histological results (Fig 4.3b), the classifier correctly detected the location of the 
advanced lesion in this case. The two-class SVM yielded the ROC curve (Fig 4.4), with 
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the area under curve (AUC) =0.97. 
  
Table 3“Leave-one-out” cross-validation results of automatic lesion stage SVM classifier 
compared to true histology class. 
 SMC Early Advanced 
Histology 
classification 
105 43 54 
Correctly 
classified 
93 25 50 




Fig 4.3 a) Color-coded classified sample points overlaid on MRI, with the same color 









The lesion-stage classification accuracies based on one or all of the parameters are 
compared in Table 4.4. For the single parameter classifiers, PD outperforms the other two 
parameters in detecting SMC; T1 has a higher accuracy in detecting early-stage and 
advanced disease. Indeed in the present study, T1 yields the highest sensitivity and 
specificity in differentiating diseased from healthy tissue. However, combining all three 
parameters generates the highest overall accuracy.  
 
  










In this work, we demonstrated that high-resolution vessel wall T1, T2, PD, and 
lipid imaging is achievable using IV detector at 3T. The multi-parametric mapping allows 
absolute comparisons that do not depend on timing and instrumental factors that affect 
T1- and T2-weighted images. This potentially offers a more rigorous and reproducible 
basis for quantifying and discriminating vessel disease. We labeled the vessel wall T1, T2, 
and PD values with the histology-based findings and used them to train a machine-
learning SVM classifier to differentiate atherosclerotic lesion stage using the MRI 
parameters. The automatic classifier demonstrated a three-class differential accuracy of 
approximately 90%, with an AUC of 0.97 in ROC analysis for disease detection. 
Few studies have been published reporting vessel wall multi-parametric mapping 
with clinical scanners at 3T. Most vessel wall-mapping studies, regardless of the field 
strength, were focused on T2 mapping[85, 104] because T2 is believed to be a better 
disease indicator [104, 123]. However, in the present study, we showed that T1 and PD 
also provide substantial contrast between lesions of different stages. The T1 difference in 
vessel wall components was also illustrated in a study by Dalager-Pedersen et al. [124] at 
a, T1 b, T2 c, PD 
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9.4 T, which is the only report we could find that reports both T1 and T2 values for 
atherosclerotic tissue components confirmed by histology. The measured T1 and T2 values 
in the present study lie in the range of previously published values [85, 102-105], 
although the published values generally show poor agreement with each other.  
As indicated in Table 4.2, no single contrast alone can be used to distinguish all 
three classes, although one or two classes are separable in one of these single parameter 
maps. Consequently, using all three contrasts allows more accurate classification in the 
3D feature space (Fig 4.2). The three-class SVM classifier is robust to varying 
environmental conditions. For instance, SVM is able to produce the correct tissue class in 
refrigerated or formalin-fixed specimens with reduced T1 and T2 (results not shown). Sun 
et al.[125] performed plaque characterization with a fuzzy C-means-based classifier 
using only T2; thus, the classifier may produce error results when T2 is not measured 
under normal tissue conditions. Moreover, SVM partitions the 3D space with decision 
planes such that the normal vectors to the planes correspond to the direction in which the 
data points from the adjacent two classes are maximally separated. That is, the weighted 
images corresponding to the normal direction of the decision plane should provide the 
maximum contrast to distinguish the two adjacent classes.  
A previous study at clinical field strength 1.5T reported that the AHA classes are 
differentiable using qualitative criteria based on the appearance of atherosclerotic plaques 
on T1-, T2-, PD-weighted and time-of-flight MRI with an overall accuracy of 80.2% 
[106]. Our studies indicate that T1, T2, and PD contain sufficient information to 
discriminate the atherosclerotic lesion stage. The SVM classifier based on the three 
contrasts should more precisely enable identification of atherosclerotic components and 
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AHA class, rather than merely provide a rough estimation of disease stage. Unfortunately, 
fresh human vessel specimens exhibiting various atherosclerotic components are difficult 
to obtain, and in the present study, the limited training data constrained our classifier to ≤ 
3 classes. 
The 3T endoscopic IV antenna has been shown to successfully perform real-time 
high-resolution imaging in vivo on clinical scanners[126]. MR endoscopy has advantages 
compared to other imaging modalities such as ultrasound and optical coherence 
tomography (OCT), in its ability to generate versatile multi-parameter contrast.  With the 
imaging methods and classification algorithms described herein, endoscopic MRI opens 
the potential for real-time high-resolution detection of cardiovascular disease.  
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Chapter 5. Quantitative Stem Cell Tracking using 
Multinuclear MRI and CT 
5.1 Introduction 
Peripheral artery disease (PAD), caused by atherosclerotic plaque in vessels 
outside the heart, affects approximately eight million Americans and 12-14% of the 
population worldwide with a significant reduction in quality of life [127]. Up to a third of 
PAD patients are no longer candidates for conventional treatments, e.g., surgical or 
endovascular revascularization, primarily due to the excessive surgical risk or an 
unfavorable vascular environment [128]. To address this, a novel stem cell (SC) therapy 
has been demonstrated to be effective in improving vascularization and reducing pain at 
rest [129, 130] apparently due to paracrine mechanisms rather than direct differentiation 
into new blood vessels [131, 132]. However, current cell therapy suffers from low cell 
survival and a lack of means to monitor cell engraftment.  
Cellular therapy using microencapsulated bone-marrow-derived mesenchymal 
stem cells (MSCs) could provide a novel means to improve vascularization in PAD 
patients, and enable cell tracking by adding imaging contrast agent to the microcapsules 
[129]. Using a rabbit PAD model, this laboratory previously demonstrated ~65% of 
improvement in hind limb perfusion after 14 days of the administration of X-ray-visible 
microencapsulated MSCs as compared to empty capsules [132]. Recently, our group has 
developed a PFOB-containing microcapsule, XMRCap, that not only provides an 
immune isolation for stem cells, but also enables noninvasive cell tracking in vivo with 
19F MRI, ultrasound (US) and X-ray [133, 134].  
Noninvasive cell tracking using clinical imaging systems (e.g., MRI, CT, PET, 
US, etc.) is important as it enables targeted imaging of cells non-invasively, non-
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destructively, and repetitively in vivo [135, 136]. Among those, MRI, being a high 
resolution imaging modality that provides versatile soft tissue contrast without ionizing 
radiation, is particularly suitable for tracking stem cell engraftment and assessing the 
treatment efficacy [137]. SPIO-based MRI cell-tracking techniques, which induce strong 
local field distortion, have been widely adopted for their high sensitivity [4, 138]. 
However, the artifacts created by SPIO-labeled cells can distort the underlying 
anatomical MRI. Alternatively, 19F is particularly suitable as a tracer for MR tracking 
because it doesn’t alter the underlying anatomical image.  While endogenous 19F 
concentrations are negligible in the body, 19F MRI could be advantageous for fluorinated 
cell tracking by generating positive signals with comparable imaging sensitivity to 1H 
MRI [5, 6]. Moreover, the 19F MR signal intensity is directly proportional to the number 
of 19F atoms, offering the potential of 19F concentration quantification.  
 Quantifying the administered microcapsules containing therapeutic cells would 
not only provide a measure of cell fate, but could also be useful for determining whether 
re-intervention or repeat treatment is necessary. However, efforts to perform such studies 
have thus far proved elusive. In order to quantify XMRCaps and test whether they can 
monitor cell fate, the following properties would be desirable: 1) that XMRCaps provide 
sufficient SNR and CNR in both CT and MR images; 2) that PFOB in the XMRCaps is 
stable and provides constant signal over the studies; and 3) that XMRCaps protect and 
constrain the cells for the duration of serial imaging.  In this study, we have performed 
volume and concentration quantification of XMRCaps containing either xenogeneic 
(Xeno-) or allogeneic (Allo-) MSCs, in serially non-invasive tracking using flat-panel, 
high resolution C-arm CT and 19F MRI, both in vitro and in vivo in rabbits, by comparing 
 94 
the signals to concentration references. To address the XMRCaps property of immune-
rejection prevention, the variations in XMRCaps volume and concentration in vivo over 
time were studied and statistically compared between Xeno- and Allo-XMRCaps. 
5.2 Materials and Methods 
5.2.1 Phantom preparation  
 Empty XMRCaps with a diameter of 300±16 µm were produced using a modified 
alginate-poly-L-lysine microencapsulation process containing 12% PFOB, as described 
previously[133, 139]. Eight 0.5 ml microcentrifuge tubes were filled with empty 
XMRCaps at various concentrations: Tubes 1 to 5 were packed with maximum 0.5 ml 
XMRCaps, while Tubes 6-8 contained 0.25 ml XMRCaps well mixed with 0.25 ml 5% 
agarose gel (Sigma Chemical, St. Louis, MO, USA). To avoid the MRI susceptibility 
artifacts at the edge of the tubes, the tubes were immersed in containers filled with gelatin 
or agarose gel. 
 Four reference markers (M1-M4) made with maximally packed empty XMRCaps 
containing either 6%, 12% or 20% PFOB served as concentration standards to measure 
XMRCaps concentrations and correct for receiver coil sensitivity. M1 is a 0.5ml 
microcentrifuge tube, M2-M4 are the square tubes with a dimension of 1.2 x1.2 x3 cm3. 
In addition, four surface markers were taped to each phased-array of the receiver coil to 
assist with the visualization of the coil location in 19F MRI studies. 
5.2.2 In vivo delivery of XMRCaps 
All animal procedures were approved by the Johns Hopkins Institutional Animal 
Care and Use Committee. Microencapsulation of male rabbit MSCs (AlloSCs) or human 
MSCs (XenoSCs) was performed using the same method as empty XMRCaps but with 
the incorporation of MSCs at density of 6.0 x106 cells/ml. Female New Zealand White 
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rabbits (n=10, weight 5-8kg) were sedated with ketamine (40 mg/kg) and acepromazine 
(1 mg/kg) intramuscularly, induced with propofol and intubated. General anesthesia was 
maintained with 1.5-2% isoflurane mixed with oxygen. Hind limb ischemia was induced 
in 5 of the 10 rabbits using a minimally invasive endovascular technique in the left 
superficial femoral artery (SFA) as previously described [140, 141]. 24 hours after SFA 
occlusion, PAD rabbits (n=5) received 6 intramuscular injections (~0.5ml /injection) of 
AlloSC XMRCaps into the ischemic left thigh. The normal rabbits (n=5) received 6 
injections of XenoSC XMRCaps in the left thigh. The rabbits were positioned on a plastic 
V-board to ensure minimum movements between the imaging modalities. M1-M4 were 
attached to the animals (n=9) prior to imaging as shown in Fig. 5.1. The animals were 





Fig 5.1 19F MRI (red) of markers (M1-M4) fused with axial maximum intensity projection 
(MIP) of 1H MRI to indicate the location of the markers to the rabbit. (M1: 6% PFOB 
XMRCaps filled in a 0.5 ml tube; M2: 12% PFOB XMRCaps in a 4.3ml tube; M3, M4: 
20% PFOB XMRCaps in 4.3ml tubes). The coil (dash) was placed on top of the rabbit 




5.2.3 C-arm CT imaging protocol 
Phantom C-arm CT images were acquired on a flat-panel X-ray fluoroscopic 
system (Siemens Axiom Artis dFA, 20 second DynaCT preset, 240° scan angle; 0.5° 
increment; 0.36 µGy dose per pulse; and 48 cm FOV). Secondary reconstructions were 
performed using the vendor’s software to yield a 0.39 mm3 isotropic voxel size. In vivo 
C-arm CT images were acquired on the same system using the 8s body dynamic 
subtraction angiogram (DSA) preset and reconstructed at 0.46 mm3 isotropic voxel size.  
5.2.4 MR imaging protocol 
MRI was performed on a 3.0 T MR system (Siemens Tim Trio). Phantom 1H and 
19F MRI were acquired in the coronal plane. 1H MRI was acquired with the system’s 
body matrix coil using a GRE sequence for geometry reference (15 ms TR, 3.7 ms TE, 
118 x 252 x 108mm3 FOV; 0.49 x 0.49 x 1.5mm3 voxel size; 20° FA; and 320 Hz/pixel 
receiver bandwidth). 19F MR signals were acquired with a custom flexible coil consisting 
of a single-loop transmit coil and four phased array receivers. A B0 field shim on the 
region of interest (ROI) was performed before imaging. 19F MRI was performed with a 
3D True fast imaging with steady state precession (TrueFISP) sequence (4.1ms TR, 
2.0ms TE, 32 signal averages, 289 x 208 x 88mm3 FOV, 1.5 x 1.5 x 2mm3 voxel size and 
1002 Hz/pixel receiver bandwidth).  
In vivo MRI was performed using imaging parameters identical to those in the 
phantom studies with FOV adjusted to the animal size. The 19F coil was positioned in the 
coronal plane at a fixed distance from the V-board to minimize depth variations in 
longitudinal quantification due to coil positioning. To test the repeatability of 19F MRI, 
XenoSC Rabbit1 was imaged and then re-imaged on the same day with the 19F coil 
repositioned between acquisitions. 
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5.2.5 Image segmentation and quantification 
For visualization, the phantom and in vivo 1H and 19F MRI were registered and 
fused using the Siemens LEONARDO Syngo product workstation, and plotted in the 
same orientation for comparison. 
Image segmentation and quantification were performed in Matlab (2013a, 
Mathworks, Natick, MA). Otsu segmentation [142] was performed in 3D ROIs to 
segment XMRCaps volumes in phantom CT, phantom 19F MR and in vivo 19F MR 
images. The in vivo CT images were thresholded with the lower bound of µst + 6σst (µst: 
soft tissue intensity mean, σst: soft tissue intensity standard deviation), and the upper 
bound of µXMR+6σXMR (µXMR: XMRCaps intensity mean, σXMR: XMRCaps intensity 
standard deviation). Volumes from CT were used as the standard. 
19F image intensities or CT Hounsfield units (HU) were converted to PFOB 
concentrations for quantification. Phantom CT HU numbers were normalized to the 
highest mean HU number of the phantom tubes, which was assumed to consist of pure 
XMRCaps containing 12% PFOB. The in vivo CT was calibrated by extrapolating from 
the HU numbers of the markers that consist of 12% and 20% PFOB XMRCaps. The 19F 
MR image intensities were corrected by the reference 19F coil’s sensitivity profile. The 
field profile function was created using the intensities of the markers located at different 
depth obtained from three studies. The intensities were fitted to an exponential decay as a 
function of depth, using minimum least-square fitting. The function was scaled for each 
individual study to compensate for variations in the receiver gain.  
5.2.6 Histological analysis 
After humane euthanasia at the final imaging session, the hind limb tissue 
containing XMRCaps was harvested for histological analysis. H&E staining was 
 98 
performed to evaluate the microcapsule integrity. Human cell viability was determined by 
an anti-human nuclear antigen (HuNa) staining. 
5.2.7 Statistical analysis 
The alternations in XMRCaps volumes and concentrations in AlloSC and 
XenoSC rabbits were reported as percentage mean ± SD. To interpret these variations, 
two-way analysis of variance (ANOVA) with repeated measures was performed over 
time after delivery and cell type (R, version 3.1.1, Vienna, Austria). A probability of 
p<0.05 was considered statistically significant.  
5.3 Results 
The 19F MRI intensities in M1-M3 were plotted as a function of the distance from 
the coil, r, after normalized to their 19F concentration (Fig.5.2). The field profile function 
fit to the exponential decay was: 




Fig 5.2 Mean signal intensities of M1-M3 in each slice vs. distance from the coil after 
normalization to its known concentration. Data points are fitted to the exponential 
function for receiver B1 field correction. 
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Both CT and MRI phantom images provided a clear contrast between agarose and 
XMRCaps (Fig. 5.3A-B). The microcentrifuge tubes in the MRI and CT images were 
morphologically highly correlated. The tube volumes and the PFOB concentrations 
quantified from MRI and CT were highly consistent (Fig.5.3 C-D), with a relative 
volume deviation of 0.3±12%, and a relative concentration deviation of 3.4±13%. Tubes 
3 and 6, placed at 5.8 and 6.6 cm from the coil, were excluded in Fig.5.3C-D, due to the 
low 19F MRI SNR in those tubes.  
 
Fig 5.3 CT and MRI studies of the phantom consisting 8 tubes of fully (Tubes 1,2,3,5,7) 
or half (Tubes 4,6,8) concentrated XMRCaps. (A) A gray scale DynaCT image and (B) a 
gray scale 1H MRI fused with a hot scale 19F MRI of the phantom with tube number 
labeled. The quantification results from19F MRI and CT images of tube volumes (C) and 
PFOB concentration (D), with the distance from the 19F coil noted in (D). Tubes 3 and 6 
were excluded due to low 19F MRI SNR at large depth. 
 
The injection sites in in vivo CT images showed high concordance to those of the 
MR image in all longitudinal studies (Fig.5.4). SNR of CT images was about 1.5 times of 
 100 
19F MRI. Because the AlloSC rabbits CT images were difficult to analyze due to the 
contamination of blooming artifact caused by the platinum coil, the available in vivo CT 
volumes were measured from 11 studies of 5 XenoSC rabbits. The volume and 
concentration quantification of in vivo CT and MRI in XenoSC rabbits showed good 
agreement. Compared to CT results, the volume and concentration deviations of 19F MRI 
results were -9.2±12% and 8.7±15% respectively (Fig.5.5). 
 
Fig 5.4 Representative CT (A-C) and fused MRI (D-F; 19F:orange, 1H:gray) images of an 
Allo-rabbit showing the injections of XMRCaps (arrow) at day 1(A,D), day 8 (B,E), and 
day 15 (C, F). The platinum coils in the CT images and M1, M3, and M4 in the MRI are 
cropped to facilitate visualization. 
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Fig 5.5  In vivo XMRCaps (A) volume and (B) concentration quantifications from MRI 
and CT images in XenoSC rabbit studies. Rabbit numbers are noted on the x-axis. Color 
codes time after delivery (Red-day 1, blue-day 8, and yellow-day 15) 
  
The segmented volumes (Fig.5.6A) and intensities (Fig.5.6B) of the markers and 
injections from the repeated 19F MRI studies are plotted vs. depth, r. The difference 
between two studies in the segmented volumes was <1.8±7.4%, and the difference in the 
signal intensities was <1.9±6.9%. 
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Fig 5.6 The reproducibility of quantitative 19F MRI in a XenoSC Rabbit, showing the 
segmented volumes (A) and the volume signal intensity (B) in each slice vs. distance 
from the coil. The results of the markers in the first (dot) and the second (circle) studies 
refer to the left axis, while the results of the injection sites in the first (triangles) and the 
second (solid triangles) studies refer to the right axis.  
 
Quantified volumes and concentrations of in vivo 19F MRI for 5 AlloSC rabbits 
(Fig.5.7, solid lines) and 5 XenoSC rabbits (Fig. 5.7, dashed lines) at days 1, 8 and 15 
were used for statistical analysis. For XMRCaps volumes, an average weekly decrease in 
AlloSC rabbits was 5±12.5% compared with 4.1%±17.4% in XenoSC rabbits. Because 
AlloSC Rabbit 2 missed the second 19F MRI study, only volumes and concentrations at 
days 1, 8, 15 of AlloSC (n=4) and XenoSC (n=5) rabbits were included in the ANOVA 
test. ANOVA testing indicated no significant difference from cell types on volumes 
(p=0.7). For all rabbits, no significant volume variation from day 1 to day 8 was observed 
(p=0.8), while a significant decrease of 12±10% was evident from day 8 to day 15 
(p=0.03). For concentrations, the average weekly decrease in AlloSC rabbits was 
1.2%±18%, which was not significant compared to 0±12% in XenoSC rabbits (p=0.41). 
No significant variations were noted in all rabbits over time after delivery during week 1 
(p=0.55) or week 2 (p=0.67). 
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Fig 5.7 The XMRCaps injection volume (A) and concentration (B) from five AlloSC 
rabbits (solid lines, refer to the left axis) and five XenoSC rabbits (dashed lines, refer to 
the right axis) at day 1, day 8 and day 15 after delivery. 
 
 
HuNa staining revealed high cell viability two weeks after administration 
(Fig.5.8A). H&E staining demonstrated XMRCaps remained intact (Fig.5.8B), which 
was consistent with CT and MR images.  
 
 
Fig 5.8 (A) Representative image of HuNa staining of the tissue from XenoSC rabbit 
shows the presence of live Xeno MSCs within XMRCaps 2 weeks after injection (green: 





In the present study, we used quantitative CT and MRI to track stem cells serially 
in rabbit models. Quantification of the number of the stem cells was achieved by 
quantifying the PFOB signal from XMRCaps. Both CT and MRI were used to assess 
XMRCaps volume and concentration in vitro and in vivo. MRI was advantageous here, 
not only for its non-ionizing radiation, but also for its simplicity and repeatability in 
segmenting the 19F hotspots from the background. The in vivo CT image segmentation 
was much more difficult due to the presence of the surrounding tissue, the metal artifacts 
from the platinum coils, or the bright vessel overlapping in the DSA images and so on.  
 The quantification of cells is based on the assumptions that the contrast agent 
remains inside the XMRCaps and that the cells are well preserved for the whole study 
period. In this study, we demonstrated no significant change in the PFOB signal of the 
XMRCaps (<5% ) over two weeks in vivo, compared to over half of the 19F signal loss 7 
days after direct cell labeling using CF3 [143]. In addition, PFOB is not only 
biocompatible as an FDA-approved blood substitute, but is also a synthetic oxygen 
carrier which sustains the cell viability. The high cell survival in the XMRCaps two 
weeks post-delivery may be attributed in part to the presence of PFOB. This agrees with 
prior studies wherein PFOB encapsulation increased cell transplantation success rates 
compared to alginate-only encapsulation [144]. Moreover, the T1 value of the PFOB may 
be potentially used to evaluate the efficacy of new vessel development, due to the 
correlation between the T1 of perfluorocarbons with the local oxygen concentration [145]. 
 Impregnating 19F into XMRCaps greatly improves the imaging sensitivity in MRI. 
The number of fluorine atoms in one voxel was in the order of 1019, ten times more than 
that from direct cell labeling with 19F [5, 146]. Thus the SNR is ten times higher. 
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However, the SNR produced by XMRCaps in 19F MRI is still very low, such that 32 
averages are required in 19F MRI. This limits the choice to only SSFP type sequences, 
which provide maximum SNR per unit time. SSFP permits us to detect as low as 
10caps/voxel [147], but has the well-known disadvantage of being the susceptible to B0 
field inhomogeneity, which causes banding artifacts. To minimize these effects, a local 
B0 field shim was performed before imaging. The banding that sometimes still appeared 
in the high volume markers (M2 in particular) were excluded when computing 
concentrations. Moreover, the PFOB spectrum contains three fluorine peaks, which may 
cause chemical shift artifacts [148]. With the PFOB spectral range being more than 20 
ppm wide [149], MRI was performed by centering the frequency on the peak that 
contained the most signal. Despite the fact that the signal from the other two peaks was 
insufficient to be visually observed in the images, we minimized the measurement error 
by acquiring 19F MRI with a large bandwidth (1002Hz/pixel), such that the induced 
chemical shift differences between the furthest peaks would not exceed three pixels.  
The CT and MR images were segmented using Otsu’s method (19F MRI and 
phantom CT) or hard thresholding (in vivo CT). Otsu’s method[142] automatically 
thresholds the image into two classes with a minimum within-class variance, and no input 
parameters are needed. It is preferable here for its adaptiveness to the imaging gain 
variations and its high repeatability, except for in vivo CT images, which consist more 
than two tissue classes. For the segmentation of in vivo CT images, the HU number of 
XMRCaps (~400) can be distinguished from that of soft tissue (~0) and bone (varies from 
700 to 3000) [150], thus thresholding with an upper and a lower bound was suitable. All 
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of the segmentation algorithms are automatic with a roughly defined-ROI, which were 
found to be 100% reproducible.  
The CT image has a voxel size that is more than 45 times smaller than that of the 
19F MR images, and no spatial field variations, thus the CT volumes were served as the 
standard. The segmented MRI volumes were consistent with CT volumes (on average 
<1% error in phantoms). However, the larger voxel size in MR reduces the accuracy of 
volume measurements due to PVE. The Otsu method was able to minimize this error by 
separating two classes based on the histogram distribution rather than merely the intensity 
values. Thus, the partially filled voxels are assigned to foreground or background with an 
optimized probability. In contrast, the hard thresholding with μ+6σ was not suitable for 
the low-resolution 19F MRI segmentation, as it mostly assigned the partially-filled voxels 
to the foreground.  
19F MRI signal is proportional to the 19F spin density, thus it is directly 
proportional to the PFOB concentration. The acquired 19F signal follows the detector 
coil’s field profile function [5.1]. An increase of the depth from 1cm to 5.8cm, for 
example, causes an 80% signal loss, resulting in the exclusion of Tube 3 and Tube 6 in 
phantom MRI analysis. This would potentially limit the effective imaging depth of the 
coil to < 6cm. A volume 19F coil is anticipated to generate a more homogenous field. The 
HU number in CT was demonstrated to be roughly linear with the physical density in 
certain tissues [151]. Although the quantification of PFOB concentration in CT was 
based on this assumption of linearity, the markers were used to calibrate out any non-
linearity or offsets. However, the underlying mechanism of CT imaging contrast is not 
directly related to molecule density, thus even though the measured concentrations were 
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consistent, MRI, rather than CT, should be treated as the standard PFOB concentration 
measurement. 
 The MRI serial tracking shows a slight decrease in the XMRCaps volumes (<5%) 
and concentration (<2%) with a high reproducibility in vivo. The lost volume is most 
likely due to the settlement of the loose XMRCaps injections and insufficient SNR. The 
concentration and volume oscillations over time reflect the measurement error. Previous 
published studies indicate that large voxels in MRI cause up to 20% errors [152, 153]. 
Imaging with smaller voxels will reduce this error, but also result in longer scan time for 
the same SNR.  
The success in in vivo XMRCaps tracking using both CT and 19MRI leads to a 
prospective therapeutic regime for PAD. XMRCaps delivery can be monitored in real-
time using CT with high-resolution. Metallic needles, which are compatible with CT, 
generate high contrast against soft tissue, ensuring the precision delivery to the target 
location. PFOB greatly improves the visibility of XMRCaps under CT for monitoring the 
injection dose. Then 19F MRI can be performed for follow-up cell tracking, which 
eliminates the patients’ exposure to ionizing radiation. In addition, with 1H MR 
angiography sequences, it is possible to monitor the SC engraftment and the treatment 
efficacy using a single imaging modality. 
 In conclusion, CT and 19F MRI of the XMRCaps provides a novel means to track 
SCs in a non-invasive fashion. Segmentation and calibration algorithms were developed 
for accurate quantification and successfully validated in both volume and concentration 
measurements. The results of serial 19F MRI tracking of the XMRCaps and the 
histological staining proved that XMRCaps prevent immunorejection. The combination 
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of the two modalities offers great potential for quantitative monitoring of therapeutic cell 
delivery and tracking engraftment in PAD therapy. Future work is needed to eliminate 





Chapter 6. Conclusion and Future Works 
6.1 Conclusion 
MRI produces soft tissue contrast superior to that of any other imaging modality, 
and is thus ideally suited to detecting soft tissue pathology. Quantification of the factors 
that characterize contrast, enables absolute comparisons between images from different 
studies, potentially providing a quantitative standard for disease diagnosis and a means of 
monitoring response to therapy. In this dissertation, we developed several quantitative 
parameter-mapping methods, and explored the potential of quantitative MRI for 
classifying vessel disease and for tracking the delivery of cell therapy. 
First, the Dual-τ T2 mapping method was introduced, which utilizes the fact that 
the spins undergo T2 decay during long adiabatic pulses. This method yields high 
accuracy in tissues with short T2s, such as muscle, cartilage and white matter. The Dual-τ 
method is relatively immune to B0 and B1 inhomogeneity, due to their use of adiabatic 
pulses. It was shown that T2 contrast can be introduced to MRI by adding a 0° FA 
adiabatic pre-pulse to an imaging sequence. The method was validated both in phantoms 
and in vivo in humans, and produced accurate T2 values compared to gold standard SE T2 
measurements. This work was published in Journal of Magnetic Resonance [69] and  a 
patent application was filed on it in 2012[154]. 
The Dual-τ method was further explored and extended for the simultaneous 
mapping of all the standard MRI contrast parameters – T1, T2, and PD. Three new 
methods with a minimum number of acquisitions were developed therefrom. In 
particular, the Four-FA method provides T1, T2, and PD maps that incorporate a B1 field 
inhomogeneity self-correction with only four acquisitions. Compared to existing mapping 
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methods, such as DESPOT1/2 or IR TrueFISP, the Four-FA method performed best 
overall in terms of accuracy, while exhibiting high efficiency per unit accuracy.  These 
methods were validated in phantoms and in vivo in the human brain, and also published 
in the Journal of Magnetic Resonance, in 2014 [115].  
After the development of novel mapping methods, the value of multi-parametric 
mapping for characterizing vessel disease was explored. We first demonstrated that high-
resolution vessel wall T1, T2, PD, and fat imaging are achievable using an IV detector at 
3T. Then, a machine-learning-based classifier was trained using the vessel wall T1, T2, 
and PD values, which were labeled with the pathology results to differentiate 
atherosclerotic lesion stages. The automatic classifier demonstrated a three-class 
differential accuracy of approximately 90%, with an AUC of 0.97 in the ROC analysis for 
disease detection. This work was presented at International Society of Magnetic 
Resonance in Medicine conferences in 2014 and 2015. 
Finally, direct quantification of the image intensities was used to measure the 
delivery and fate of an encapsulated cell therapy. We performed quantitative serial stem 
cell-tracking in rabbit models using CT and 19F MR images. Segmentation and 
calibration algorithms were developed for accurate quantification. Both CT and MRI 
were able to non-invasively assess XMRCaps volume and concentration in vitro and in 
vivo. The constant signal level during the serial 19F MRI tracking of the XMRCaps and 
the cell integrity two weeks after administration proved that the XMRCaps preparation 
could successfully avoid immunorejection. This work was presented at the World 
Molecular Imaging Conference in 2012, and the International Society of Magnetic 
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Resonance in Medicine and Society for Cardiovascular Magnetic Resonance conferences 
in 2013. 
 
6.2 Future works 
 T1, T2, and PD are the intrinsic factors that affect MRI contrast. However, long 
acquisition times are potentially limiting for clinical T1, T2, and PD mapping, and increase 
the likelihood of motion artifacts. Recently, spectroscopy with linear algebraic modeling 
(SLAM) was developed for MRS and CEST to reduce scan times up to 120-fold by 
delivering compartment-averaged spectroscopy signals that were reconstructed from a 
small subset of those k-space acquisitions with the highest SNR[155, 156]. Currently, we 
are testing the feasibility of combining SLAM with MRI to yield compartment-averaged 
T1, T2 and PD measures. In the initial attempt, the SLAM measurements were validated 
with a standard “MIX” sequence [157] in human vessel specimens with IV MRI and are 
compared with those from the conventional full k-space FT reconstruction acquired at 3T.  
A segmented FOV from a diseased vessel (myelodysplastic syndrome) is 
exemplified in Fig.6.1 (fat=F; lesion=L; vessel fluid contents=W1; smooth vessel-wall 
muscle=SM; surrounding tissue=W2). SLAM results for the vessel wall are plotted 
against acceleration factor, R in Fig. 6.2, with error-bands indicating compartment mean 
± SD measured in the FT-MIX maps. For R≤10, SLAM T1, T2, and PD measurements in 
all compartments fall within the mean ± SD of the FT results. In both lesion 
compartments (L1, L2) and F, and with R=10, errors in the three parameters are ≤ 
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0.5%(±4%) compared to the FT mean. Even in W1 and W2, where the SD of T1 and PD 
are ≥30% in the FT maps, SLAM T1 and PD agree with the FT means within ≤6%±6%. 
 




Fig 6.2 SLAM T1, T2, and PD values vs. R. The error bands denote compartment 




The initial results show that acceleration methods enable fast and accurate multi-
parametric mapping, which could satisfy the time limitations in routine clinical MRI and 
provide quantitative measures of quantitative value.  Considering this, the value of the 
multi-parametric maps should be further explored, including the creation of quantitative 
criteria for tissue component discrimination, as well as the generation of the optimum 





1. Lauterbur PC: Image formation by induced local interactions: examples 
employing nuclear magnetic resonance. Nature 1973, 242:190-191. 
2. Edeistein WA, Bottomley PA: Magnetic resonance without nuclei? Radiology 
1984, 152:237-237. 
3. Ahrens ET, Bulte JWM: Tracking immune cells in vivo using magnetic 
resonance imaging. Nat Rev Immunol 2013, 13:755-763. 
4. Kraitchman DL, Gilson WD, Lorenz CH: Stem cell therapy: MRI guidance and 
monitoring. Journal of Magnetic Resonance Imaging 2008, 27:299-310. 
5. Boehm-Sturm P, Mengler L, Wecker S, Hoehn M, Kallur T: <italic>In 
Vivo</italic> Tracking of Human Neural Stem Cells with <sup>19</sup>F 
Magnetic Resonance Imaging. PLoS ONE 2011, 6:e29040. 
6. Srinivas M, Heerschap A, Ahrens ET, Figdor CG, Vries IJM: < sup> 19</sup> F 
MRI for quantitative< i> in vivo</i> cell tracking. Trends in biotechnology 
2010, 28:363-370. 
7. Rabi II: Space Quantization in a Gyrating Magnetic Field. Physical Review 
1937, 51:652-654. 
8. Rabi II: On the Process of Space Quantization. Physical Review 1936, 49:324-
328. 
9. Isidor Isaac Rabi [http://www.britannica.com/biography/Isidor-Isaac-Rabi] 
10. Purcell EM: Spontaneous emission probabilities at radio frequencies. In.; 
1946: 681. 
11. Bloch F: Nuclear induction. Physical review 1946, 70:460. 
12. Bloembergen N, Purcell EM, Pound RV: Relaxation effects in nuclear magnetic 
resonance absorption. Physical Review 1948, 73:679. 
13. Hahn EL: Spin echoes. Physical review 1950, 80:580. 
14. Ernst RR: Nuclear Magnetic Resonance Fourier Transform Spectroscopy 
(Nobel Lecture). Angewandte Chemie International Edition in English 1992, 
31:805-823. 
15. Mansfield P: Multi-planar image formation using NMR spin echoes. Journal 
of Physics C: Solid State Physics 1977, 10:L55. 
16. Wuthrich K: NMR of proteins and nucleic acids. Wiley; 1986. 
17. Koradi R, Billeter M, Wüthrich K: MOLMOL: A program for display and 
analysis of macromolecular structures. Journal of Molecular Graphics 1996, 
14:51-55. 
18. Mallard J, Hutchison J, Edelstein W, Ling C, Foster M, Johnson G, Cox S, 
Lauterbur P, Mansfield P, Wilkie D: In vivo nmr Imaging in Medicine: The 
Aberdeen Approach, both Physical and Biological [and Discussion]. 
Philosophical Transactions of the Royal Society of London Series B, Biological 
Sciences 1980:519-530. 
19. Edelstein WA, Hutchison JM, Johnson G, Redpath T: Spin warp NMR imaging 
and applications to human whole-body imaging. Physics in medicine and 
biology 1980, 25:751-756. 
 115 
20. Yuri L, Ernst Wolfgang S, Tao Z: Novel technologies and configurations of 
superconducting magnets for MRI. Superconductor Science and Technology 
2013, 26:093001. 
21. Vaughan T, DelaBarre L, Snyder C, Tian J, Akgun C, Shrivastava D, Liu W, 
Olson C, Adriany G, Strupp J, et al: 9.4T human MRI: Preliminary results. 
Magnetic Resonance in Medicine 2006, 56:1274-1282. 
22. Schepkin VD, Brey WW, Gor'kov PL, Grant SC: Initial in vivo rodent sodium 
and proton MR imaging at 21.1 T. Magnetic resonance imaging 2010, 28:400-
407. 
23. Haacke EM, Brown RW, Thompson MR, Venkatesan R: Magnetic Resonance 
Imaging: Physical Principles and Sequence Design. St. Louis: Mosby; 1999. 
24. Nishimura DG: Principles of magnetic resonance imaging. Stanford University; 
1996. 
25. Mansfield P: Nmr imaging in biomedicine: Supplement 2 advances in magnetic 
resonance. Elsevier; 1982. 
26. Erdman WA: Biomedical Magnetic Resonance Imaging: Principles, 
Methodology, and Applications. Radiology 1990, 174:462-462. 
27. Bottomley PA, Hardy CJ, Argersinger RE, Allen-Moore G: A review of 1H 
nuclear magnetic resonance relaxation in pathology: are T1 and T2 
diagnostic? Medical physics 1987, 14:1-37. 
28. Bottomley PA, Foster TH, Argersinger RE, Pfeifer LM: A review of normal 
tissue hydrogen NMR relaxation times and relaxation mechanisms from 1–
100 MHz: Dependence on tissue type, NMR frequency, temperature, species, 
excision, and age. Medical physics 1984, 11:425-448. 
29. Stanisz GJ, Odrobina EE, Pun J, Escaravage M, Graham SJ, Bronskill MJ, 
Henkelman RM: T1, T2 relaxation and magnetization transfer in tissue at 3T. 
Magnetic resonance in medicine : official journal of the Society of Magnetic 
Resonance in Medicine / Society of Magnetic Resonance in Medicine 2005, 
54:507-512. 
30. Gold GE, Han E, Stainsby J, Wright G, Brittain J, Beaulieu C: Musculoskeletal 
MRI at 3.0 T: Relaxation Times and Image Contrast. Am J Roentgenol 2004, 
183:343-351. 
31. Kleine LJ, Mulkern RV, Guttmann CR, Colucci VM, Jolesz FA: In vivo 
characterization of cytotoxic intracellular edema by multicomponent analysis 
of transverse magnetization decay curves. Academic radiology 1995, 2:365-
372. 
32. Does MD, Snyder RE: Multiexponential T2 relaxation in degenerating 
peripheral nerve. Magnetic Resonance in Medicine 1996, 35:207-213. 
33. Frey HE, Knispel RR, Kruuv J, Sharp AR, Thompson RT, Pintar MM: Proton 
Spin-Lattice Relaxation Studies of Nonmalignant Tissues of Tumorous Mice. 
Journal of the National Cancer Institute 1972, 49:903-906. 
34. Rogers WJ, Prichard JW, Hu YL, Olson PR, Benckart DH, Kramer CM, Vido 
DA, Reichek N: Characterization of signal properties in atherosclerotic 
plaque components by intravascular MRI. Arteriosclerosis, thrombosis, and 
vascular biology 2000, 20:1824-1830. 
 116 
35. Meiboom S, Gill D: Modified Spin‐Echo Method for Measuring Nuclear 
Relaxation Times. Review of Scientific Instruments 1958, 29:688-691. 
36. Rose A: Vision: human and electronic. Springer Science & Business Media; 
2013. 
37. Feinstein A: The clinical neuropsychiatry of multiple sclerosis. Cambridge 
University Press; 2007. 
38. Erbay SH, Brewer E, French R, Midle JB, Zou KH, Lee GM, Erbay KD, Bhadelia 
RA: T2 hyperintensity of medial lemniscus is an indicator of small-vessel 
disease. AJR American journal of roentgenology 2012, 199:163-168. 
39. Chowdhury R, Wilson I, Rofe C: Radiology at a Glance. John Wiley & Sons; 
2010. 
40. Geraldes CF, Laurent S: Classification and basic properties of contrast agents 
for magnetic resonance imaging. Contrast media & molecular imaging 2009, 
4:1-23. 
41. Gilad AA, Walczak P, McMahon MT, Na HB, Lee JH, An K, Hyeon T, van Zijl 
PCM, Bulte JWM: MR tracking of transplanted cells with “positive contrast” 
using manganese oxide nanoparticles. Magnetic Resonance in Medicine 2008, 
60:1-7. 
42. Abragam A: The Principles of Nuclear Magnetism. Oxford, Clarendon Press 
1961:599. 
43. Norris DG: Adiabatic radiofrequency pulse forms in biomedical nuclear 
magnetic resonance. Concepts in Magnetic Resonance 2002, 14:89-101. 
44. De Graaf RA, Nicolay K: Adiabatic rf pulses: Applications to in vivo NMR. 
Concepts in Magnetic Resonance 1997, 9:247-268. 
45. Silver MS, Joseph RI, Hoult DI: Highly selective [pi]/2 and [pi] pulse 
generation. Journal of Magnetic Resonance (1969) 1984, 59:347-351. 
46. Hardy CJ, Edelstein WA, Vatis D: Efficient adiabatic fast passage for NMR 
population inversion in the presence of radiofrequency field inhomogeneity 
and frequency offsets. J Magn Reson 1986, 66:470-482. 
47. Garwood M, Ke Y: Symmetric pulses to induce arbitrary flip angles with 
compensation for rf inhomogeneity and resonance offsets. Journal of Magnetic 
Resonance (1969) 1991, 94:511-525. 
48. Bottomley PA, Ouwerkerk R: BIRP: an improved implementation of low-angle 
adiabatic (BIR-4) excitation pulses. J Magn Reson Ser A 1993, 103:242-244. 
49. Robin Bendall M, Garwood M, Uǧurbil K, Pegg DT: Adiabatic refocusing pulse 
which compensates for variable of power and off-resonance effects. Magnetic 
Resonance in Medicine 1987, 4:493-499. 
50. El-Sharkawy A-M, Schar M, Ouwerkerk R, Weiss RG, Bottomley PA: 
Quantitative Cardiac 31P Spectroscopy at 3 Tesla Using Adiabatic Paulses. 
Magnetic Resonance in Medicine 2009, 61. 
51. Bottomley PA, Edelstein WA: NMR imaging of the transverse relaxation time 
using multiple spin echo sequences. In Book NMR imaging of the transverse 
relaxation time using multiple spin echo sequences (Editor ed.^eds.). City: 
General Electric Company (Schenectady, NY); 1985. 
 117 
52. Bottomley PA, Ouwerkerk R: The Dual-Angle Method for Fast, Sensitive T1 
Measurement in Vivo with Low-Angle Adiabatic Pulses. Journal of Magnetic 
Resonance, Series B 1994, 104:159-167. 
53. Nezafat R, Ouwerkerk R, Derbyshire AJ, Stuber M, McVeigh ER: Spectrally 
selective B1-insensitive T2 magnetization preparation sequence. Magnetic 
Resonance in Medicine 2009, 61:1326-1335. 
54. Bottomley PA, Edelstein WA: Method of eliminating effects of spurious free 
induction decay NMR signal caused by imperfect 180 degrees pulses. In Book 
Method of eliminating effects of spurious free induction decay NMR signal caused 
by imperfect 180 degrees pulses (Editor ed.^eds.). City: General Electric 
Company (Schenectady, NY); 1984. 
55. Bittoun J, Taquin J, Sauzade M: A computer algorithm for the simulation of 
any Nuclear Magnetic Resonance (NMR) imaging method. Magnetic 
Resonance Imaging 1984, 2:113-120. 
56. Yoshimura K, Kato H, Kuroda M, Yoshida A, Hanamoto K, Tanaka A, Tsunoda 
M, Kanazawa S, Shibuya K, Kawasaki S, Hiraki Y: Development of a tissue-
equivalent MRI phantom using carrageenan gel. Magnetic Resonance in 
Medicine 2003, 50:1011-1017. 
57. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, Beer Rd, Graveron-
Demilly D: Java-based Graphical User Interface for the MRUI Quantitation 
Package. MAGMA 2001, 12:141-152. 
58. Moran PR, Hamilton CA: Near-resonance spin-lock contrast. Magnetic 
Resonance Imaging 1995, 13:837-846. 
59. Gelman N, Gorell JM, Barker PB, Savage RM, Spickler EM, Windham JP, 
Knight RA: MR Imaging of Human Brain at 3.0 T: Preliminary Report on 
Transverse Relaxation Rates and Relation to Estimated Iron Content. 
Radiology 1999, 210:759-767. 
60. Deoni SCL, Rutt BK, Peters TM: Rapid combined T1 and T2 mapping using 
gradient recalled acquisition in the steady state. Magnetic Resonance in 
Medicine 2003, 49:515-526. 
61. Schmitt P, Griswold MA, Jakob PM, Kotas M, Gulani V, Flentje M, Haase A: 
Inversion recovery TrueFISP: Quantification of T1, T2, and spin density. 
Magnetic Resonance in Medicine 2004, 51:661-667. 
62. Heule R, Ganter C, Bieri O: Triple echo steady-state (TESS) relaxometry. 
Magnetic Resonance in Medicine 2013:n/a-n/a. 
63. Bieri O, Scheffler K: On the origin of apparent low tissue signals in balanced 
SSFP. Magnetic Resonance in Medicine 2006, 56:1067-1074. 
64. Tong CY, Prato FS: A novel fast T1-mapping method. Journal of Magnetic 
Resonance Imaging 1994, 4:701-708. 
65. Look DC, Locker DR: Time Saving in Measurement of NMR and EPR 
Relaxation Times. Review of Scientific Instruments 1970, 41:250-251. 
66. Haase A, Matthaei D, Bartkowski R, Dühmke E, Leibfritz D: Inversion recovery 
snapshot FLASH MR imaging. Journal of computer assisted tomography 1989, 
13:1036. 
 118 
67. Ehses P, Seiberlich N, Ma D, Breuer FA, Jakob PM, Griswold MA, Gulani V: IR 
TrueFISP with a golden‐ratio‐based radial readout: Fast quantification of 
T1, T2, and proton density. Magnetic Resonance in Medicine 2013, 69:71-81. 
68. Ma D, Gulani V, Seiberlich N, Liu K, Sunshine JL, Duerk JL, Griswold MA: 
Magnetic resonance fingerprinting. Nature 2013, 495:187-192. 
69. Wang G, El-Sharkawy AM, Edelstein WA, Schär M, Bottomley PA: Measuring 
T2 and T1, and imaging T2 without spin echoes. J Magn Reson 2012, 214:273-
280. 
70. Fram EK, Herfkens RJ, Johnson GA, Glover GH, Karis JP, Shimakawa A, 
Perkins TG, Pelc NJ: Rapid calculation of T1 using variable flip angle 
gradient refocused imaging. Magnetic Resonance Imaging 1987, 5:201-208. 
71. Freeman R, Hill H: Fourier transform study of NMR spin–lattice relaxation 
by “Progressive Saturation”. The Journal of Chemical Physics 1971, 54:3367. 
72. Edelstein WA, Bottomley PA, Hart HR, Smith LS: Signal, noise, and contrast in 
nuclear magnetic resonance (NMR) imaging. J Comput Assist Tomogr 1983, 
7:391-401. 
73. Bottomley PA, Ouwerkerk R: BIRP, an improved implementation of low-angle 
adiabatic (BIR-4) excitation pulses. J Magn Reson Ser A 1993, 103:242-244. 
74. Volz S, Nöth U, Deichmann R: Correction of systematic errors in quantitative 
proton density mapping. Magnetic Resonance in Medicine 2012, 68:74-85. 
75. Wansapura JP, Holland SK, Dunn RS, Ball WS: NMR relaxation times in the 
human brain at 3.0 tesla. Journal of Magnetic Resonance Imaging 1999, 9:531-
538. 
76. Ethofer T, Mader I, Seeger U, Helms G, Erb M, Grodd W, Ludolph A, Klose U: 
Comparison of longitudinal metabolite relaxation times in different regions 
of the human brain at 1.5 and 3 Tesla. Magnetic Resonance in Medicine 2003, 
50:1296-1301. 
77. Stanisz GJ, Odrobina EE, Pun J, Escaravage M, Graham SJ, Bronskill MJ, 
Henkelman RM: T1, T2 relaxation and magnetization transfer in tissue at 3T. 
Magnetic Resonance in Medicine 2005, 54:507-512. 
78. Deoni SCL: High-resolution T1 mapping of the brain at 3T with driven 
equilibrium single pulse observation of T1 with high-speed incorporation of 
RF field inhomogeneities (DESPOT1-HIFI). Journal of Magnetic Resonance 
Imaging 2007, 26:1106-1111. 
79. Yarnykh VL: Actual flip-angle imaging in the pulsed steady state: A method 
for rapid three-dimensional mapping of the transmitted radiofrequency field. 
Magnetic Resonance in Medicine 2007, 57:192-200. 
80. Joseph PM, Axel L, O’Donnell M: Potential problems with selective pulses in 
NMR imaging systems. Medical physics 1984, 11:772. 
81. Schär M, Vonken E-J, Stuber M: Simultaneous B0- and B1+-Map acquisition 
for fast localized shim, frequency, and RF power determination in the heart 
at 3 T. Magnetic Resonance in Medicine 2010, 63:419-426. 
82. Edelstein WA, Bottomley PA: Method of three-dimensional NMR imaging 
using selective excitation. In Book Method of three-dimensional NMR imaging 
using selective excitation (Editor ed.^eds.). City: Google Patents; 1984. 
 119 
83. Crawley AP, Henkelman RM: A comparison of one‐shot and recovery methods 
in T1 imaging. Magnetic Resonance in Medicine 1988, 7:23-34. 
84. Cheng HLM, Wright GA: Rapid high‐resolution T1 mapping by variable flip 
angles: Accurate and precise measurements in the presence of 
radiofrequency field inhomogeneity. Magnetic Resonance in Medicine 2006, 
55:566-574. 
85. Biasiolli L, Lindsay A, Chai J, Choudhury R, Robson M: In-vivo quantitative 
T2 mapping of carotid arteries in atherosclerotic patients: segmentation and 
T2 measurement of plaque components. Journal of Cardiovascular Magnetic 
Resonance 2013, 15:69. 
86. Hurley SA, Yarnykh VL, Johnson KM, Field AS, Alexander AL, Samsonov AA: 
Simultaneous variable flip angle–actual flip angle imaging method for 
improved accuracy and precision of three-dimensional T1 and B1 
measurements. Magnetic Resonance in Medicine 2012, 68:54-64. 
87. Hinshaw WS: Image formation by nuclear magnetic resonance: The 
sensitive&#x2010;point method. Journal of Applied Physics 1976, 47:3709-
3721. 
88. Carr HY: Steady-State Free Precession in Nuclear Magnetic Resonance. 
Physical Review 1958, 112:1693-1701. 
89. El-Sharkawy A-MM, Qian D, Bottomley PA, Edelstein WA: A multichannel, 
real-time MRI RF power monitor for independent SAR determination. 
Medical physics 2012, 39:2334. 
90. Venkatesan R, Lin W, Haacke EM: Accurate determination of spin-density and 
T1 in the presence of RF-field inhomogeneities and flip-angle miscalibration. 
Magnetic Resonance in Medicine 1998, 40:592-602. 
91. Gras V, Abbas Z, Shah NJ: Spoiled FLASH MRI with slice selective excitation: 
Signal equation with a correction term. Concepts in Magnetic Resonance Part 
A 2013, 42:89-100. 
92. Mathers C, Fat DM, Boerma J: The global burden of disease: 2004 update. World 
Health Organization; 2008. 
93. Organization WH: World health statistics 2014. World Health Organization; 
2014. 
94. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, Rosenfeld 
ME, Schwartz CJ, Wagner WD, Wissler RW: A definition of advanced types of 
atherosclerotic lesions and a histological classification of atherosclerosis A 
report from the Committee on Vascular Lesions of the Council on 
Arteriosclerosis, American Heart Association. Circulation 1995, 92:1355-
1374. 
95. Xu W-H, Li M-L, Gao S, Ni J, Zhou L-X, Yao M, Peng B, Feng F, Jin Z-Y, Cui 
L-Y: In vivo high-resolution MR imaging of symptomatic and asymptomatic 
middle cerebral artery atherosclerotic stenosis. Atherosclerosis 2010, 212:507-
511. 
96. Ryu CW, Jahng GH, Kim EJ, Choi WS, Yang DM: High resolution wall and 
lumen MRI of the middle cerebral arteries at 3 tesla. Cerebrovascular 
diseases (Basel, Switzerland) 2009, 27:433-442. 
 120 
97. Swartz R, Bhuta S, Farb R, Agid R, Willinsky R, Butany J, Wasserman B, 
Johnstone D, Silver F, Mikulis D: Intracranial arterial wall imaging using 
high-resolution 3-tesla contrast-enhanced MRI. Neurology 2009, 72:627-634. 
98. Qiao Y, Steinman DA, Qin Q, Etesami M, Schär M, Astor BC, Wasserman BA: 
Intracranial arterial wall imaging using three-dimensional high isotropic 
resolution black blood MRI at 3.0 Tesla. Journal of Magnetic Resonance 
Imaging 2011, 34:22-30. 
99. Touboul P-J, Elbaz A, Koller C, Lucas C, Adraï V, Chédru F, Amarenco P, 
Investigators G: Common Carotid Artery Intima-Media Thickness and Brain 
Infarction The Étude du Profil Génétique de l’Infarctus Cérébral (GÉNIC) 
Case-Control Study. Circulation 2000, 102:313-318. 
100. Bottomley P, Hardy C, Argersinger R, Allen‐Moore G: A review of 1H nuclear 
magnetic resonance relaxation in pathology: are T1 and T2 diagnostic? 
Medical physics 1987, 14:1-37. 
101. Rogers WJ, Prichard JW, Hu Y-L, Olson PR, Benckart DH, Kramer CM, Vido 
DA, Reichek N: Characterization of Signal Properties in Atherosclerotic 
Plaque Components by Intravascular MRI. Arteriosclerosis, Thrombosis, and 
Vascular Biology 2000, 20:1824-1830. 
102. Dalager-Pedersen S, Falk E, Ringgaard S, Kristensen IB, Pedersen EM: Effects of 
temperature and histopathologic preparation on the size and morphology of 
atherosclerotic carotid arteries as imaged by MRI. Journal of Magnetic 
Resonance Imaging 1999, 10:876-885. 
103. Coolen BF, Poot DH, Liem MI, Smits LP, Gao S, Kotek G, Klein S, Nederveen 
AJ: Three‐dimensional quantitative T1 and T2 mapping of the carotid 
artery: Sequence design and in vivo feasibility. Magnetic Resonance in 
Medicine 2015. 
104. Raynaud J-S, Bridal SL, Toussaint J-F, Fornès P, Lebon V, Berger G, Leroy-
Willig A: Characterization of atherosclerotic plaque components by high 
resolution quantitative MR and US imaging. Journal of Magnetic Resonance 
Imaging 1998, 8:622-629. 
105. Mihai G, Giri S, Sharkey-Toppen TP, Raman SV, Rajagopalan S, Simonetti PP: 
Quantitative T1, T2 and T2* Mapping of Carotid Artery Normal Wall and 
Atherosclerotic Plaque. International Society of Magnetic Resonance in 
Medicine 2011. 
106. Cai J-M, Hatsukami TS, Ferguson MS, Small R, Polissar NL, Yuan C: 
Classification of human carotid atherosclerotic lesions with in vivo 
multicontrast magnetic resonance imaging. Circulation 2002, 106:1368-1373. 
107. Saam T, Ferguson MS, Yarnykh VL, Takaya N, Xu D, Polissar NL, Hatsukami 
TS, Yuan C: Quantitative Evaluation of Carotid Plaque Composition by In 
Vivo MRI. Arteriosclerosis, Thrombosis, and Vascular Biology 2005, 25:234-
239. 
108. Martin AJ, Plewes DB, Henkelman RM: MR imaging of blood vessels with an 
intravascular coil. Journal of Magnetic Resonance Imaging 1992, 2:421-429. 
109. Ocali O, Atalar E: Intravascular magnetic resonance imaging using a loopless 
catheter antenna. Magnetic resonance in medicine 1997, 37:112-118. 
 121 
110. Sathyanarayana S, Bottomley PA: MRI endoscopy using intrinsically localized 
probes. Medical Physics 2009, 36:908-919. 
111. El-Sharkawy AM, Qian D, Bottomley PA: The performance of interventional 
loopless MRI antennae at higher magnetic field strengths. Med Phys 2008, 
35:1995-2006. 
112. Hastie T, Tibshirani R, Friedman J, Hastie T, Friedman J, Tibshirani R: The 
elements of statistical learning. Springer; 2009. 
113. Cortes C, Vapnik V: Support-vector networks. Machine learning 1995, 20:273-
297. 
114. Suykens JAK, Vandewalle J: Least Squares Support Vector Machine 
Classifiers. Neural Processing Letters 1999, 9:293-300. 
115. Wang G, El-Sharkawy A-MM, Bottomley PA: Minimum acquisition methods 
for simultaneously imaging T1, T2, and proton density with B1 correction 
and no spin-echoes. Journal of Magnetic Resonance 2014, 242:243-255. 
116. Jara H, Fleming K, Sakai O: PD, T1, and T2 quantitative MRI spectroscopy of 
the orbit: An application of the Mix-TSE pulse sequence. In 12th Scientific 
Meeting and Exhibition of the International Society for Magnetic Resonance in 
Medicine, Kyoto, Japan. 2004 
117. Jensen M, Caruthers S, Jara H: Quantitative magnetic resonance imaging with 
the mixed turbo spin-echo pulse sequence: A validation study. Internet 
Journal of Radiology 2001, 2. 
118. Glover GH, Schneider E: Three-point dixon technique for true water/fat 
decomposition with B0 inhomogeneity correction. Magnetic Resonance in 
Medicine 1991, 18:371-383. 
119. Wang G, El-Sharkawy A-MM, Bottomley PA: Minimum Acquisition Methods 
for Simultaneously Imaging T1, T2, and Proton Density with B1 Correction 
and No Spin-echoes. J Magn Reson. 
120. Hellings WE, Moll FL, de Kleijn DPV, Pasterkamp G: 10-years experience with 
the Athero-Express study. Cardiovascular Diagnosis and Therapy 2012, 2:63-
73. 
121. Li K-C: Asymptotic Optimality for Cp, CL, Cross-Validation and 
Generalized Cross-Validation: Discrete Index Set. The Annals of Statistics 
1987, 15:958-975. 
122. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver 
operating characteristic (ROC) curve. Radiology 1982, 143:29-36. 
123. Martin AJ, Gotlieb AI, Henkelman RM: High-resolution MR imaging of human 
arteries. Journal of Magnetic Resonance Imaging 1995, 5:93-100. 
124. Morrisett J, Vick W, Sharma R, Lawrie G, Reardon M, Ezell E, Schwartz J, 
Hunter G, Gorenstein D: Discrimination of components in atherosclerotic 
plaques from human carotid endarterectomy specimens by magnetic 
resonance imaging ex vivo. Magn Reson Imaging 2003, 21:465-474. 
125. Sun B, Giddens DP, Long R, Taylor WR, Weiss D, Joseph G, Vega D, Oshinski 
JN: Automatic plaque characterization employing quantitative and 
multicontrast MRI. Magnetic Resonance in Medicine 2008, 59:174-180. 
 122 
126. Sathyanarayana S, Schär M, Kraitchman DL, Bottomley PA: Towards Real-
Time Intravascular Endoscopic Magnetic Resonance Imaging. JACC: 
Cardiovascular Imaging 2010, 3:1158-1165. 
127. Shammas NW: Epidemiology, classification, and modifiable risk factors of 
peripheral arterial disease. Vascular Health and Risk Management 2007, 3:229. 
128. Fadini GP, Agostini C, Avogaro A: Autologous stem cell therapy for 
peripheral arterial disease: Meta-analysis and systematic review of the 
literature. Atherosclerosis 2010, 209:10-17. 
129. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, 
Amano K, Kishimoto Y, Yoshimoto K, Akashi H, et al: Therapeutic 
angiogenesis for patients with limb ischaemia by autologous transplantation 
of bone-marrow cells: a pilot study and a randomised controlled trial. The 
lancet 2002, 360:427-435. 
130. Ransohoff JD, Wu JC: Imaging stem cell therapy for the treatment of 
peripheral arterial disease. Current vascular pharmacology 2012, 10:361. 
131. Kinnaird T, Stabile E, Burnett M, Shou M, Lee C, Barr S, Fuchs S, Epstein S: 
Local delivery of marrow-derived stromal cells augments collateral perfusion 
through paracrine mechanisms. Circulation 2004, 109:1543-1549. 
132. Kedziorek DA, Hofmann LV, Fu Y, Gilson WD, Cosby KM, Kohl B, Barnett BP, 
Simons BW, Walczak P, Bulte JW: X‐Ray‐Visible Microcapsules Containing 
Mesenchymal Stem Cells Improve Hind Limb Perfusion in a Rabbit Model 
of Peripheral Arterial Disease. Stem Cells 2012, 30:1286-1296. 
133. Kedziorek DA, Solaiyappan M, Walczak P, Ehtiati T, Fu Y, Bulte JW, Shea SM, 
Brost A, Wacker FK, Kraitchman DL: Using C-Arm X-Ray Imaging to Guide 
Local Reporter Probe Delivery for Tracking Stem Cell Engraftment. 
Theranostics 2013, 3:916. 
134. Arifin DR, Kedziorek DA, Fu Y, Chan KW, McMahon MT, Weiss CR, 
Kraitchman DL, Bulte JW: Microencapsulated cell tracking. NMR in 
Biomedicine 2013, 26:850-859. 
135. Bulte JW, Kraitchman DL: Iron oxide MR contrast agents for molecular and 
cellular imaging. NMR Biomed 2004, 17:484-499. 
136. Nahrendorf M, Sosnovik DE, French BA, Swirski FK, Bengel F, Sadeghi MM, 
Lindner JR, Wu JC, Kraitchman DL, Fayad ZA: Multimodality cardiovascular 
molecular imaging, Part II. Circulation: Cardiovascular Imaging 2009, 2:56-
70. 
137. Fu Y, Azene N, Xu Y, Kraitchman DL: Tracking stem cells for cardiovascular 
applications in vivo: focus on imaging techniques. Imaging in medicine 2011, 
3:473-486. 
138. Ahrens ET, Bulte JW: Tracking immune cells in vivo using magnetic 
resonance imaging. Nature Reviews Immunology 2013, 13:755-763. 
139. Barnett BP, Arepally A, Stuber M, Arifin DR, Kraitchman DL, Bulte JWM: 
Synthesis of magnetic resonance-, X-ray- and ultrasound-visible alginate 
microcapsules for immunoisolation and noninvasive imaging of cellular 
therapeutics. Nat Protocols 2011, 6:1142-1151. 
140. Liddell RP, Patel TH, Weiss CR, Lee DS, Matsuhashi T, Brown P, Gabrielson 
KL, Rodriguez ER, Eng J, Kimura H: Endovascular model of rabbit hindlimb 
 123 
ischemia: a platform to evaluate therapeutic angiogenesis. Journal of vascular 
and interventional radiology 2005, 16:991-998. 
141. Patel TH, Kimura H, Weiss CR, Semenza GL, Hofmann LV: Constitutively 
active HIF-1α improves perfusion and arterial remodeling in an 
endovascular model of limb ischemia. Cardiovascular research 2005, 68:144-
154. 
142. Otsu N: A threshold selection method from gray-level histograms. Automatica 
1975, 11:23-27. 
143. Maki J, Masuda C, Morikawa S, Morita M, Inubushi T, Matsusue Y, Taguchi H, 
Tooyama I: The MR tracking of transplanted ATDC5 cells using fluorinated 
poly-L-lysine-CF3. Biomaterials 2007, 28:434-440. 
144. Khattak SF, Chin KS, Bhatia SR, Roberts SC: Enhancing oxygen tension and 
cellular function in alginate cell encapsulation devices through the use of 
perfluorocarbons. Biotechnology and bioengineering 2007, 96:156-166. 
145. McGovern KA, Schoeniger JS, Wehrle JP, Ng CE, Glickson JD: Gel-entrapment 
of perfluorocarbons: A fluorine-19 NMR spectroscopic method for 
monitoring oxygen concentration in cell perfusion systems. Magnetic 
Resonance in Medicine 1993, 29:196-204. 
146. Srinivas M, Morel PA, Ernst LA, Laidlaw DH, Ahrens ET: Fluorine-19 MRI for 
visualization and quantification of cell migration in a diabetes model. 
Magnetic resonance in medicine 2007, 58:725-734. 
147. Fu Y, Kedziorek D, Shea S, Ouwerkerk R, Huang G, Ehtiati T, Krieg R, Bulte 
JWM, Kraitchman DL: Novel 19F MRI and CT Trackable Microencapsulated 
Mesenchymal stem cells for treating peripheral arterial disease Journal of the 
American College of Cardiology 2010, 55:A216.E2049-A2216.E2049. 
148. Lee H, Nalcioglu O, Buxton R: Correction for chemical‐shift artifacts in 19F 
imaging of PFOB: Simultaneous multislice imaging. Magnetic resonance in 
medicine 1991, 21:21-29. 
149. Yildirim M, Keupp J, Nicolay K, Lamerichs R: Chemical shift independent 
imaging of 19F contrast agents using ultrafast MRSI (F-uTSI). 
150. Hounsfield GN: Computed medical imaging. Medical Physics 1980, 7:283-290. 
151. Ciarelli MJ, Goldstein SA, Kuhn JL, Cody DD, Brown MB: Evaluation of 
orthogonal mechanical properties and density of human trabecular bone 
from the major metaphyseal regions with materials testing and computed 
tomography. Journal of orthopaedic research : official publication of the 
Orthopaedic Research Society 1991, 9:674-682. 
152. González Ballester MÁ, Zisserman AP, Brady M: Estimation of the partial 
volume effect in MRI. Medical Image Analysis 2002, 6:389-405. 
153. González Ballester MÁ, Zisserman A, Brady M: Segmentation and 
measurement of brain structures in MRI including confidence bounds. 
Medical Image Analysis 2000, 4:189-200. 
154. Bottomley PA, Wang G, Abdel-monem M: Systems and methods for measuring 
nuclear magnetic resonance spin-lattice relaxation time t1 and spin-spin 
relaxation time t2. In Book Systems and methods for measuring nuclear 
 124 
magnetic resonance spin-lattice relaxation time t1 and spin-spin relaxation time 
t2 (Editor ed.^eds.). City: Google Patents; 2012. 
155. Zhang Y, Gabr RE, Schär M, Weiss RG, Bottomley PA: Magnetic resonance 
Spectroscopy with Linear Algebraic Modeling (SLAM) for higher speed and 
sensitivity. Journal of Magnetic Resonance 2012, 218:66-76. 
156. Zhang Y, Gabr RE, Zhou J, Weiss RG, Bottomley PA: Highly-accelerated 
quantitative 2D and 3D localized spectroscopy with linear algebraic modeling 
(SLAM) and sensitivity encoding. Journal of Magnetic Resonance 2013, 
237:125-138. 
157. Cuppen J: RLSQ: T1, T2, and ρ calculations, combining ratios and least 







 Date of Birth: June-02-1987; Xi’an, China 
 Email: wangg62@gmail.com 
Education 
 PhD:  Johns Hopkins University   Baltimore, MD 2009-2015 
Electrical and Computer Engineering 
Advisor: Paul A. Bottomley 
 M.Sc.: Johns Hopkins University   Baltimore, MD 2009-2012 
Electrical and Computer Engineering 
 B.Sc.: Xi’an Jiaotong University  Xi’an, China  2005-2009 
Biomedical Engineering 
Teaching 
 Class assistant: Johns Hopkins University  Baltimore, MD  Sep-Dec 2013  
Basics of Wave & Quantum Mechanics 
Publications 
Patent 
1. P.A. Bottomley, G. Wang, A.M. EI-Sharkawy. Systems and methods for 
measuring nuclear magnetic resonance spin-lattice relaxation time t1 and spin-
spin relaxation time t2, US 20130141096 A1 
Peer-reviewed Journal Articles  
1. G. Wang, A.M. El-Sharkawy, P.A. Bottomley. Minimum acquisition methods for 
simultaneously imaging T1, T2, and proton density with B1 correction and no 
spin-echoes. Journal of Magnetic Resonance 242 (2014) 243–255. 
2. G. Wang, A.M. El-Sharkawy, W.A. Edelstein, M. Schär, P.A. Bottomley. 
Measuring T2 and T1, and imaging T2 without spin echoes. Journal of Magnetic 
Resonance 214 (2012) 273-280. 
3. G. Wang, X. Wu, S. Wang, X. Guo. Comparison of DNA sequences in gene 
regulation regions according to the existence of transcription factor binding sites. 
Beijing Biomedical Engineering, 2009, 28(002): 170-174. 
4. L.C. Rose, D.K. Kadayakkara, G. Wang, A. Bar-shir, B.M. Helfer, C.F. 
O’Hanlon, D.L. Kraitchman, R.L. Rodriguez, J.W.M Bulte. Fluorine-19 Labeling 
 126 
of Stromal Vascular Fraction Cells for Clinical Imaging Applications. Stem Cells 
Translational Medicine(2015):sctm.2015-0113. 
Conference Abstracts 
1. G. Wang, M.A. Erturk, S.S. Hegde, P.A. Bottomley. Automated classification of 
vessel disease based on high-resolution intravascular multi-parametric mapping 
MRI. International Society for Magnetic Resonance in Medicine Annual Meeting 
2015. 
2. G. Wang, A.M. El-Sharkawy, P.A. Bottomley. Imaging T1, T2 and proton density 
with minimum possible acquisitions. International Society for Magnetic 
Resonance in Medicine Annual Meeting 2014. 
3. G. Wang, M.A. Erturk, S.S. Hegde, P.A. Bottomley. High-resolution multi-
parametric characterization of atherosclerotic lesions with 3T intravascular MRI. 
International Society for Magnetic Resonance in Medicine Annual Meeting 2014. 
4. G. Wang, Y. Fu, S. Shea, J. Cook, D. Kraitchman. Quantitative 19F MRI and CT 
tracking of the microencapsulated stem cells in a rabbit peripheral arterial disease 
model. Journal of Cardiovascular Magnetic Resonance, 16(Suppl 1, 2014): P61. 
5. G. Wang, Y. Fu, S.M. Shea, D.L. Kraitchman. Quantitative 19F MRI and CT 
tracking of the microencapsulated stem cells in peripheral arterial disease model. 
International Society for Magnetic Resonance in Medicine Annual Meeting 2013, 
Salt Lake City, Utah. 
6. G. Wang, Y. Fu, S.M. Shea, J.A. Cook, D.L. Kraitchman. CT and 19F MR 
imaging for quantitative tracking of encapsulated mesenchymal stem cells in a 
peripheral arterial disease model. World Molecular Imaging Congress 2012, 
Dublin, Ireland. 
7. G. Wang, A.M. El-Sharkawy, W.A. Edelstein, M. Schär, and P.A. Bottomley. 
Measuring T1 and T2 and proton density in 3 acquisitions: the Tri-τ method. 
International Society for Magnetic Resonance in Medicine Annual Meeting 2012, 
Melbourne, Australia. 
8. G. Wang, A.M. El-Sharkawy, W.A. Edelstein, M. Schar, and P.A. Bottomley. 
Measuring T2 and T2-imaging without echoes? International Society for 
Magnetic Resonance in Medicine Annual Meeting 2011, Montreal, Canada. 
 
